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Abstract 
 
One of the main concerns in multi-centre clinical trials is how to enrol an adequate number of 
patients during a specific period of time. Accordingly, the sponsors are keen to minimise the 
recruitment time for cost effectiveness purposes.  
 
This  research tended to concentrate on  forecasting the patients’ accrual  time for the pre-
arranged number of sample size by simulating an on-going trial. The method was to model the 
data  from  the  recruitment  frequency  domain  and  apply  the  estimations  derived  from  the 
frequency domain to predict the time domain.  
 
Whereas previous papers did not concentrate on variations of recruiting over centres, this 
research assumed that patient arrivals followed the Poisson process and let the parameter of 
the  process  vary  as  a  Gamma  distribution.  Consequently,  the  Poisson-gamma  mixed 
distribution was confirmed as the promising model of the frequency domain. Then with the 
help of the relationship between the Poisson process and the exponential distribution, accrual 
time was predicted assuming that the waiting time between patients followed the Gamma-
exponential distribution.  
 
As the result of the project, a trial was simulated based on the estimated values derived from 
completed trials.  The first part of the prediction estimated the expected average number of 
patients per centre per month in an on-going trial. The second part, predicted the length of 
time (in months) to enrol specific number of patients in the simulated trial.     iii 
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Chapter 1 
Literature and Approach 
 
1.1. Introduction 
A clinical trial is an experiment in which human subjects are exposed to medical treatment to 
understand the effects of the treatment for their well-being [9]. One of the main concerns in 
multi-centre clinical trials is to enrol sufficient numbers of patients during a specific period. 
The numbers of patients recruited over time may reflect the intended study sample size but 
also the capabilities of participating centre. Some clinical trial delays are due to inadequate 
accrual of patients [11] but most are because of delay in recruitment.  
Investigators need robust and reliable statistical tools to deal with the stochastic variations 
occurring in patient accrual rates. The recruitment rate may also vary depending on several 
factors such as the time of the year, the capacity of the centre [7], the number of staff [1], the 
popularity of the centre and the nature and the population of the local area. Consequently, 
with good planning tools, researchers would be able to reach a reasonable sample size rather 
than a sample size that could not be achieved during the trial period. Efficient recruitment 
planning tools can also reduce the number of centres required in clinical trials.   Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  2 
Recruitment time, however, is a fundamental aspect to the success of planning multi-centre 
clinical trials and appears to be even more important compared to the recruitment sample size. 
Due  to  it  being  costly,  recruitment  time  is  the  biggest  obstacle  in,  for  example,  drug 
development trials. On the one hand, in order to compete with other treatments and prevent 
loss of sales [1], the recruitment period should be shorter. If the recruitment time is too long, 
it can cost the sponsor revenue since a competing treatment may be released to the market 
first [9]. On the other hand, an inadequate number of patients may reduce the power of the 
trial  [9].  Very  often,  in  real  trials,  the  number  of  patients  that  can  be  recruited  is  over 
estimated and the length of time to accomplish the trial is under estimated [8]. 
The primary objective of this thesis is to propose a method to predict patient recruitment 
across a fixed time length as well as modelling accrual time for pre-arranged sites and patient 
number. 
 
1.2. Reviewing literatures 
In reviewing the literature the aim was to identify publications dealing with the modelling of 
patient recruitment in order to see first, whether any suitable methods are available with easy 
implementation and second, if not, what further work would be needed. 
In order to gain some overall knowledge of the requirements of analysing multi-centre clinical 
trials; the starting point was chapter 14 of Statistical Issues in Drug Development by Senn 
[1].  In the next step, to find the other currently existing statistical approaches in modelling 
patient enrolment,  English language papers were searched for: ‘recruitment’, ‘clinical trial’, 
‘predicting’, ‘recruitment time’, ‘patient recruitment’, ‘multicentre’, ‘multi-centre’, ‘accrual Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  3 
periods’, ‘recruitment period’, ‘modelling’ and ‘enrolment’. To find the source journals, I 
used  the  Google®  search  engine.  Salience  was  determined  by  reviewing  the  abstract 
identified. Then, using the server of the University of Glasgow, I was able to download the 
salient full texts. In fact, after I registered for EndNote®, an alternative approach was possible 
and consequently, I had access to more papers through PubMed®. The references at the end 
of each paper were also employed to identify relevant papers.  In addition, in response to an 
email  sent  to  a  leading  authority  in  the  field,  Vladimir  Anisimov  (who  is  an  honorary 
Professor in the School of Mathematics and Statistics at University of Glasgow and Senior 
Director in Research Statistics Unit at GlaxoSmithKline), I was kindly sent some of his papers 
as well as chapter 25 [4] of his book.  
Among the numerous papers found, not all were of relevance for our research. I retained those 
papers focusing directly upon modelling patient recruitment, predicting the patient enrolment 
or predicting recruitment period for clinical trials.  
 
1.2.1.  Summary of various papers 
The papers were summarised by grouping them chronologically by the first paper by the lead 
author. The most important publications which encompass the topic were  those by Williford 
et al [6], Haidich et al [7], Carter et al [8,9], Abbas et al [10], Anisimov et al [2-5] and 
Gajewski et al [11]. This summary briefly describes the main statistical approaches proposed 
by the authors, followed by the application of the models suggested. Furthermore, an overall 
summary is provided at the end of this review. The reader, requiring a basic overview, may 
wish to skip to the following descriptions of  individual papers.  
 Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  4 
 Williford et al [6] 
Williford  et  al  [6]  propose  a  negative  binomial  distribution  as  a  mixture  of  Poisson 
distributions  for  modelling  the  recruitment  data.  They  discuss  that  although  the  basic 
assumption, usually made when enrolling patients, is that the recruitment rate is constant; this 
is not always true in real trials. This is evidenced from several NIH (National Institutes of 
Health)  funded  multi-centre  clinical  trials  [15-17].  Nevertheless,  based  on  a  constant 
recruitment rate, the number of patients enrolled in a trial is normally supposed to arise from a 
Poisson  distribution.  After  testing  the  adequacy  of  the  Poisson  model,  they  suggest  the 
parameter of the Poisson distribution, which is the average of recruitment rates, varies based 
on a gamma distribution. The outcome is a Negative Binomial.  
This is an early paper using a Poisson-gamma mixture. This approach is discussed in more 
detail under Anisimov below. 
 
 Haidich et al [7] 
In a particular database lunched by the AIDS Clinical Trial Group (ACTG) including a large 
set of over 700 trials with overall 120000 enrolments, Haidich et al [7] examined whether 
quarterly patients enrolment could be modelled to predict the number of new studies as well 
as  the  recruitment  time  and  the  effect  of  large  trials.  The  relationship  between  the 
performance of large studies and enrolment, which accelerated over time, were significant in 
multivariate autoregressive modelling applied in SPSS. Observing the current trend and its 
variations was potentially beneficial for predicting future recruitment time.  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  5 
They  then  showed  that  for  a  fixed  sample  size,  the  recruitment  rate  differs  significantly 
between different months, seasons and centres as well as being influenced by launching large 
studies. The capacity of centres and the sample size play important roles in the number of 
patients arriving to participate in the trial. The effect of large studies, however, increases the 
overall patient intake, which is due to the huge demands on enrolling patients.  
 
 Carter et al [8, 9] 
In a particular multi-centre effectiveness study, Carter et al [8] proposed three methods. In 
another paper [9], they propose the stochastic process to support theoretically the final method. 
In fact, with the help of the Poisson process and simulation, they provide a model to estimate 
the  recruitment  time.  At  the  beginning  of  the  trial,  Carter  seeks  the  basic  historical 
information  of  each  centre  through  questionnaires  including  the  total  number  of  subjects 
which have been entered in the centres [8].  
One model considered an unconditional approach, which is, to divide the whole sample size 
by the total expected recruitment rate in individual centres. This method would be feasible 
only  if  all  the  centres  initiate  recruitment  simultaneously.  In  reality,  an  unconditional 
approach  cannot  be  applied if there  are  gaps between starting  timesamongst  participating 
centres [8]. To deal with this variation, Carter suggests a conditional approach depending on 
the recruitment rate in each centre and the length of the time each site recruits patients for.  
In the two methods discussed above, since the number of participants in each time period and 
in each centre is assumed to be fixed, the variation of the estimated rate is not taken into 
account [9]. Carter has demonstrated in his third method to deal with the variation in the Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  6 
average number of patients over time at each centre that patients are assumed to enter the trial 
according to a Poisson process. Carter concludes that a Poisson distribution can be applied to 
model the recruiting probabilities according to  the rate assumptions [9]. This approach is 
mostly useful when a clinical trial is designed to accrue the requisite number of patients in a 
finite time [8].  
Overall, they recommend applying the conditional approaches for most multi-centre trials. 
However, in the case of uncertainty in the recruitment rate, a Poisson method is suggested [8]. 
 
 Abbas et al [10] 
Abbas et al indicate that the Markov model simulation has mostly been used in clinical trials 
for other purposes than patient recruitment such as evaluation of the benefits of treatments. 
However, in their paper, they use a Monte Carlo Markov simulation model for modelling 
recruitment patterns. In the interest of calculating the recruitment time, depending on the 
availability  and  accessibility  of  the  data,  Abbas  et  al  [10]  consider  either  continuous  or 
discrete  time  variables.  In  order  to  increase  the  validity  of  the  model,  they  regard  the 
continuous time variables if the investigator knows that patients arrive one by one over time. 
In contrast, if the only available information is the average rate of arrivals in a particular time, 
the recruitment time needs to be considered as a discrete variable.  
In the first simulation method (SM1)[10], with a constant pre-arranged probability p, not all 
the patients arriving to the centre are recruited. In fact, p plays the role of a filter to prevent 
patients passing from arrival phase to recruited phase. However, it is still assumed that the 
recruitment  time  is  a  continuous  variable.  There  is  also  a  random  variable  R,  which  is Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  7 
generated from a uniform distribution between 0 and 1, to be compared with p to decide if a 
patient is recruited (R<=p). As a result, the remaining time is highly related to p, such that the 
duration increases when the probability p decreases. Due to containing a probabilistic factor, 
the simulation needs to be repeated many times in order to calculate the variability of t. The 
simulation would stop when it reaches the target sample size. The next simulation method 
(SM2) considers the case of having no idea about what p might be. It, then, can be produced 
randomly from the uniform distribution. This is the only difference between SM1 and SM2. 
In this case, it is expected to reach the same average recruitment time as what we get with 
constant p=0.5! As a result, in a special case the two last methods could be merged in a 
particular case.  
In the third simulation model (SM3), Abbas et al apply a discrete time variable, in which a 
group of patients arrive during a period of time T. The ultimate goal is to estimate the number 
of enrolled patients in each period of time. The patients who fail to be recruited (if R<p) are 
contacted again in the ensuing trial. The process continues throughout the time period, and the 
number of patients is recorded. Simulation model 3 fixes the length of recruitment time and 
estimates the mean number of patients at the end of the period. However, in SM4 (fourth 
simulation model), the objective is to calculate the expected delay of recruitment or remaining 
time. Such that the patients are recruited with a controlling fixed p but they are not replaced 
from the population. 
 
 Anisimov et al [2-5] 
Since a robust method is required to plan for enrolling patients in multi-centre trials, a model 
is sought to deal with the uncertainties observed in practice. Vladimir V. Anisimov [2] and Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  8 
Anisimov et al [3] propose a Poisson-Gamma approach for modelling patient recruitment. It is 
assumed  that  patients  arrive  in  the  centres  independently  [4,  5].  Therefore,  the  Poisson 
process is the most common and suitable distribution for the rate of patients recruiting in 
centres  [1].  In  a  Poisson  distribution,  the  average  rate  of  patient  arrival,  which  is  the 
parameter of the model, is unchanged. However, due to some differences among centres such 
as size, number of staff, number of patients in the area and type of centre, the rate may vary 
among centres [2, 3]. Therefore, Anisimov et al [3, 5] let the rates vary, as samples coming 
from a Gamma distribution. That means that the simulation is performed in two steps, first a 
sample of rates of size N (N is the number of centres) is taken from a Gamma distribution. 
The patients are then enrolled according to a Poisson process with these sample rates [5]. This 
aspect of modelling leads to the use of an empirical Bayesian approach since the recruitment 
rate  can  be  a  random  variable  in  the  ‘prior’  distribution.  The  Gamma  distribution  is 
particularly convenient because it is a distribution of non-negative variables and the mean of a 
Poisson is, of course, non-negative. With this technique the number of centres with zero or 
few participants could be evaluated as well [2, 5]. The Poisson –Gamma recruitment model 
has been validated for large centres (>20) through GlaxoSmithKline (GSK) studies. Moreover, 
the techniques, to predict the additional number of centres to be added to complete the trial, 
are also suggested [3].  
 
In order to estimate the shape parameter of the recruitment model with a Gamma distributed 
rate,  supposing  that  all  the  centres  initiated  at  the  same  time, Anisimov  [5]  uses  three 
estimation  techniques:  the  Method  of  Maximum  Likelihood,  the  Least  Squares  and  the 
Method of Moments. Then he runs a Monte Carlo simulation method to compare the three 
estimation methods. All three methods, he concludes, are similar for large sample sizes and Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  9 
centres. The number of centres plays a more essential role in effective parameter estimation, 
though.  
Regarding the analysis of recruitment time, Anisimov et al [4] have also considered three 
enrolment policies.  One of which is competitive time, in which the enrolment stops whenever 
the total number of patients reaches the pre-arranged sample size. The second policy is the 
balanced  time  in  which  all  the  centres  should  reach  a  fixed  number  of  patient  arrivals. 
According to calculations, the recruitment time in this case can be longer that the competitive 
time.  Opposed  to  the  two  former  analyses,  in  the  third  approach,  in  which  there  are 
restrictions on the number of patients recruited by centres, Anisimov et al have not come to a 
closed solution. However, they conclude that it should be something between competitive 
times and balanced times [4]. Nevertheless, the real trial may not be flexible to incorporate 
into a particular model once the trial has started.  
 
 Gajewski et al [11] 
In order to calculate the patient recruitment rate in a clinical trial, Byron J. Gajewski et al [11] 
propose a Bayesian approach. With the help of Bayesian posterior predictive distributions 
derived from prior knowledge, they provide a model to estimate the average waiting time 
between  each  patient.  Hence,  the  overall  recruiting  time  would  be  calculated  for  a  fixed 
sample size. In addition, if the arrival process is to stop after a particular time, the model can 
predict the expected number of patients by the end of the trial.  
Gajewski et al suppose that the waiting time is exponentially distributed with parameter (the 
parameterisation has not been mentioned in the paper!) and a conjugate prior distribution for Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  10 
  is the inverse gamma distribution. In a particular case, the prior distribution is supposed to 
be an Inverse Gamma distribution with parameters nP and TP, in which n is the prior sample 
size, T is the waiting time and P is the weighting factor for accuracy of n and T according to 
the  historical  information.  In  an  example,  Gajewski  et  al  [11]  compare  three  methods  of 
predicting the waiting time and the total length of the trial. The first is only to consider the 
information at the beginning of the study. Hence, the average waiting time is distributed as an 
Inverse  Gamma  (nP,TP).  The  second  approach  relies  solely  on  observed  data  from  the 
ongoing  trial.  The  third  suggestion,  however,  is  to  take  advantage  of  both  the  prior 
information  and  the  observations  from  the  ongoing  trial.  As  a  result,  this  third  approach 
culminates in an Inverse Gamma distribution in which the shape parameter is nP plus the 
number of observed patients in the current trial and the scale parameter is TP plus the time 
period, in which they have experienced the real recruitment. The authors conclude that the 
posterior with informative prior estimation (third approach) shows the faster rate of prediction 
compared to applying only the information at the outset of the study or using the observed 
data only.  
 
It  should  be  noted  that  if  the  number  of  events  in  a  given  interval  follows  the  Poisson 
distribution, then inter-arrival times lead to an exponential distribution. Thus, the basic model 
in this approach can be regarded as being the time domain equivalent of the frequency domain 
model considered by Anisimov. 
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1.2.2.  Overall conclusions based on reviewing papers 
Based on reviewing the papers, a number of issues can be identified as follows: 
1.2.2.1.  General appropriate approach to modelling patient 
recruitment  
Almost none of the approaches discussed above focused deeply on variations in recruiting 
among centres. They did not concentrate on the variations in recruiting over time either. 
Also, it is obvious that in real trials the rates of patient intake cannot be fixed. As a result, 
a tentative conclusion is that the Poisson-Gamma model is a promising approach. The 
Poisson-Gamma model lets the rates vary as random variables from Gamma distributed 
samples. The patient arrivals are then assumed to follow the Poisson distribution with the 
average rate being derived from Gamma distribution. The model originally was proposed 
by Williford et al in the context of clinical trials [6] but has been extensively developed by 
Anisimov [2-5].  
 
1.2.2.2.  Variations and risk factors that should be 
considered to optimise the model 
Anisimov  emphasised  that  recruitment  rates  are  not  fixed  in  real  trials.  Haidich  [7] 
concluded the various factors such as time of the year and the influences of large sample 
size are significant. Gaps between centres such as the differences in capacity and the 
popularity of the centres and the numbers of staff, which Senn [1] highlights, should be 
taken into account.  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  12 
1.2.2.3.  Clarity and feasibility of the applying model 
In his discussion, Abbas [10] does not consider a statistical model for the waiting times 
between patients. Hence, it is not clear which statistical distribution the time follows for 
the suggested simulation models.  
In all his approaches, Carter [8, 9] assumes the average patients’ arrival rates are fixed 
although he considers the variation regarding the initiation time. The conditional approach 
has not been sufficiently clarified enough to be practically applicable for large clinical 
trials.  
Haidich’s  time  series  method  is  primarily  designed  to  analyse  the  risk  factors  of  the 
recruitment period focusing upon the reasons for delays rather than on a mature model for 
recruiting patients.  
Gajewski [11], in contrast, proposes a Bayesian approach for the waiting time, which is 
more practical and easier to apply. However, Anisimov [2-5] expands the statistical model 
with the interest of feasibility and supporting the idea theoretically as well. The Poisson-
Gamma  distribution  is  more  reliable  to  apply;  but  it  is  complicated  compared  to 
Gajewski’s approach.  
 
1.3. Aims 
From  reviewing  the  literature,  possible  modelling  approaches  to  predict  the  patient 
recruitment prior to the start of the study were identified. The next step for the on-going trial, 
however, would be to predict the patient recruitment and accrual times with respect to the Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  13 
frequency domain
1 and the time domain
2 respectively. Therefore, it is proposed that to fulfil 
these aims for the present project the future approaches are adopted: 
  Initially, the plan is to apply the theory of Vladimir Anisimov to model the frequency 
data as well as the time data. But in the case of any practical issue in modelling the 
recruitment data the aim is to apply an alternative model for the recruitment sample 
data. 
  The  models  in  the  literature  will  be  applied  to  identify  a  suitable  model  for  the 
frequency and time domain.  
  Test for the suitability of the fitted distributions. 
  Use the alternative methods in case of unsuitable fitted models.  
  Estimate the parameters based on Maximum Likelihood Estimation. 
  Check the possible  correlations  between parameters  in  case  they are dependent  in 
order to make the modelling process easier.  
  Model the estimated parameters to gain the prior distribution of parameters 
  Apply  Bayesian  forecasting to  predict patient  recruitment  founded upon  predictive 
distribution and simulation 
   
                                                 
1 Frequency domain is the number of pat 
ients that are recruited in centres in a clinical trial. 
2 Time domain is the length of time (in the current research project the unit of time was set to months) to recruit 
patients in clinical centres.  
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Chapter 2 
Recruitment Data Description  
 
The first step in modelling the patient recruitment in multi-centre clinical trials is to identify 
and  collect  some  possible  prior  information  from  previous  trials.  The  aim  is  to  employ 
previous data and observations in clinical trials to forecast the required patient arrivals for a 
given trial even though the patients are not recruited yet. The forecast may not be exact but it 
will produce enough information to set a plan based on these historical data and experiences; 
otherwise, the trial experiment would be very intuitive and inaccurate. For this reason, ICON 
Clinical Research, the sponsor of this MSc project, provided data from completed studies in 
Excel spread sheet format. Each trial dataset consists of site codes and country information, 
number  of  patients’  arrivals  in  clinical  centres;  and  start  and  finish  recruitment  dates  in 
centres.  
 
Table 2.1 illustrates the general feature of the historical data provided by ICON. It includes 18 
completed trials (column 1) with the number of clinical centres in each trial (column 2). Next 
(column  3)  is  the  total  number  of  recruited  patients  in  the  studies  accompanied  by  the 
minimum (column 4) and maximum (column 5) number of patients in the centres in each trial. Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  15 
The last two columns summarise the minimum and the maximum length of time (in months) 
that have taken to recruit patients in the trials.    
 
 
2.1. Software platforms 
All the analyses were performed in Statistical Analysis Software (SAS®) version 9.2 and 
package  R  2.12.1.  R  is  freely  downloadable  from  http://www.r-project.org/,  but  SAS  is 
licensed and was only accessible from the university computers. Microsoft Excel was also 
used for making new data sheets and some graphical applications.  
 
2.2. Frequency domain 
Although the studies vary a lot regarding the number of clinical centres and patients (table 
2.1), the general features of the Kernel density curves [21] in the frequency domain follow a 
similar statistical distribution (figures 2.1). A Kernel density curve is a graphical and non-
parametric method of estimating the probability density functions. Kernel density curves and 
histograms are closely related. In a histogram, the horizontal axis is divided into bins, which 
should cover the whole range of the data. For a kernel density, each point is allocated to a 
normal kernel density. The individual kernels are added up to make the kernel estimate. The 
advantage of the kernel density is its smoothness compared to the histogram.  
 
R produces the kernel density curves in the MASS package (Appendix 1). In SAS, however, 
‘kernel’ option in the UNIVARIATE procedure superimposes the kernel density curve on the 
histogram.  Many different  kernel  densities are  possible but  just the default one has  been 
applied in this project.  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  16 
 
Study 
code 
N  
(number 
of sites) 
n  
(total 
number of 
patients) 
Min number 
of patients in 
clinical 
centers 
Maximum 
number of 
patients in 
clinical centers 
Minimum 
recruitment 
time 
Maximum 
recruitment 
time 
1  24  385  2  77  7.30  14.70 
2  12  152  2  28  0.40  3.13 
3  24  811  4  76  0.97  18.23 
4  16  80  1  17  0.97  3.00 
5  25  244  2  26  0.97  9.76 
6  66  796  1  48  16.23  34.80 
7  110  1126  0  41  0.33  7.27 
8  141  1241  0  40  0.57  14.80 
9  51  927  2  67  7.30  14.70 
10  150  2000  0  63  4.67  16.30 
11  97  2936  0  115  3.50  7.90 
12  75  546  0  20  3.27  6.47 
13  270  4363  0  263  2.97  28.30 
14  410  3274  0  59  3.60  35.73 
15  30  103  0  9  5.23  21.80 
16  92  533  0  60  1.80  12.57 
17  26  549  1  76  2.60  10.03 
18  60  1696  3  122  6.47  21.00 
Table 2.1: General information about the 18 completed clinical trial studies 
 
 
In figure 2.1, histograms of the frequency data of the 18 studies are illustrated as well, which 
are accompanied by the fitted Negative Binomial distributions (solid lines on the histograms).  
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Figure  2.1:  Histograms  of  the  frequency  data  with  the  fitted  Negative Binomial  curves  (left)  and  the 
Kernel density curves (right) in studies 
 
Histogram of recruited patients with fitted NB in Study 18  Kernel Density of patients in Study 18 
Histogram of recruited patients with fitted NB in Study 17  Kernel Density of patients in Study 17 
Histogram of recruited patients with fitted NB in Study 16  Kernel Density of patients in Study 16 Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  23 
The initial aim is to model the patient recruitment process for each completed study. It is, in 
fact, to find a feasible distribution for the recruitment data in order to be able to assess how 
many patients arrive into the clinical centres during a maximum recruitment time in a real on-
going trial.  
 
2.3. Time domain 
Analysing the accrual time (length of time to recruit patients), however, appears to be more 
important in clinical trials. This is due to the fact that in clinical trials the number of patients 
to be recruited is usually arranged in advance. Therefore, the companies know how many 
patients and centres are needed for a clinical trial. As a result, with a pre-arranged sample size 
and  number  of  clinical  centres,  predicting  the  required  time  to  recruit  patients  becomes 
essential. That is, a critical question when designing studies on how long will the studies take 
to recruit a pre-defined number of patients given a pre-specified number of centres.  Hence, 
the length of time to recruit patients was also to be modelled for forecasting the maximum 
recruitment time. Nevertheless, there were some problems with the time data that had to be 
addressed for the prediction purpose.  
 
The first issue was inadequacy of information about the individual patients’ arrival dates to 
the clinical centres. Only the total recruitment period for each centre was available in most 
trials. It meant that there was very little information about the waiting time between patient 
arrivals in clinical centres. It, then, made the analysis of the waiting time between patients 
more challenging.  The possible solution was simulation, which is discussed in chapter 6.  
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The second issue was the lack of compatibility between the distribution of  the frequency 
domain and the distribution of the time domain. The density of the recruitment time data was 
not similar to what was expected in Anisimov’s theory [3]. This problem is evidenced from 
the histograms and kernel density curves of the time data (figure 2.2). Overall, the arrival 
times  in  the trials  do  not  follow  a  similar  distribution.  The  general  characteristics  of  the 
accrual time are illustrated in figures 2.2. The issue is expanded in chapter 3 and an analytical 
solution has been provided as well. 
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Figure 2.2: Probability histograms of patients’ accrual times (months) in centres and estimated Kernel 
density curves 
 
 
 
 
The units of the time domain were set to months throughout the analysis. Specifying the units 
of time in the time domain should be compatible with the units of time in the frequency 
domain. Rescaling the units from one domain to the other one would end up getting very 
different values in estimating the mean and variance of the distribution of the time domain 
and results in different parameters.  Prof. Stephen Senn has highlighted this aspect in his notes 
and explained that it is the BETA parameter that is affected not the ALPHA parameter.  (See 
appendix 2) 
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Chapter 3 
Modelling the Recruitment Data 
 
 
3.1. Modelling the frequency domain 
Exploring the distributions of the variables in a data set is a fundamental step in data analysis. 
As discussed in the literature review chapter, the promising statistical model for the patient 
arrivals to clinical centres was the Poisson–Gamma mixture distribution. 
 
The advantage of the Poisson–Gamma mixed model is that it lets the rate of patient arrivals, 
for a given centre; vary as a random realisation from a Gamma distribution. Then, patient 
arrivals at a centre are assumed to follow the Poisson distribution with the average rate given 
by the Gamma variable. 
 
In the case that the mean parameter varies in the population but follows a Gamma distribution, 
the Poisson process can be suitably replaced by the Negative Binomial distribution. That is 
why the Negative Binomial distribution is more flexible in modelling the count data than the 
Poisson model. In contrast to the Poisson distribution in which the mean and variance are 
identical, in a Negative Binomial distribution the mean is smaller than the variance.   
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In this section, the recruitment data are modelled in the frequency domain assuming that they 
follow the Negative Binomial distribution. Then two methods of estimating the parameters are 
discussed and compared. Finally the goodness of fit test is developed to assess the suitability 
of the fitted model to the frequency data. However, it should be emphasised that only the 
frequency data have been modelled and the recruitment time has not been taken into account 
yet.  
A further model, taking into account the recruitment time, will be discussed in chapter 5. 
 
 
3.1.1.  Distribution of the recruitment frequency data 
 
If  it  is  assumed  that  there  are  N  clinical  centres  and  each  centre  recruits    N i ni ,..., 1 ,   
patients with the recruitment rate  i  ; then the distribution of i x , patient arrivals in centre i , 
follows the Poisson distribution with mean  i   and probability density function 
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If, however,  i   is Gamma distributed with shape parameter   and scale parameter   and  
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Then by multiplying  the Poisson and Gamma function together and integrating out the 
unknown  lambda  [12],  the  outcome  would  be  a  Negative  Binomial  distribution  with 
parameters    r  and 
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1
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In another word: 
If  ) ( ~  poisson x &      , ~ Gamma   


 



 


1
1
, ~ p r NB x  
With      
  

  
 
    
 
2 2 2 2 1               (3.4) 
If, however, it is supposed that all the clinical centres initiate simultaneously and each centre 
recruits  i n  patients during a fixed time period t , the total number of patients recruited up to 
time t  follows the Negative Binomial distribution with parameters  N   and 

t
[3] and the 
probability density: 
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Since  all  the  centres  are  activated  at  the  same  time  the variation  in  initiation  date  is  not 
included  in  (3.5).  Nevertheless,  the  recruitment  time  from  trial  to  trial  may  vary  due  to 
different  nature  and  structure  of  the  studies.  This  aspect  is  considered  in  modelling  the 
frequency domain in equation (3.5) as it follows the Negative Binomial distribution.  
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3.1.2.  Parameter estimation 
Before analysing the data, we need to assess the values of the parameters and translate this 
information into a sort of prior distribution for the parameters. The marginal distribution of 
the frequency data was  modelled as a Poisson–Gamma mixture, which led to a Negative 
Binomial distribution. But, in order to use this model the value of the parameters should be 
known.  Since  the  parameters  of  the  Negative  Binomial  distribution  were  unknown,  the 
Maximum Likelihood (ML) estimation and Method of Moments (MM) were applied in R as 
well as SAS® to estimate the parameters.  
 
3.1.2.1.  Maximum likelihood estimation 
The log-likelihood function of a Negative Binomial distribution with the probability function 
(3.3) is 
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And the log-likelihood function from the equation (3.5) is  
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The parameters were estimated by writing programs in R (see appendix 1) and also applying 
two different procedures in SAS®.  
 
In R, the ‘function’ statement was applied to construct the Negative Binomial log-likelihood 
function then the ‘optim’ statement estimated the maximum likelihood of the parameters. To 
proceed with this estimation process, R requires initial values of the parameters. Hence, from 
the trial data the minimum numbers of patients in the completed trials were set as starting Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  31 
points for ; and the starting point for  were derived with the help of method of moments 
from  (3.4)  as 

) (x E .    ‘fitdistr’  in  the  MASS  package  can  also  estimate  the  MLE  of  the 
parameters.  
 
A straight-forward way to solve the estimation problem in SAS® is applying the Negative 
Binomial null model in the GENMOD procedure. The parameters to be estimated in PROC 
GENMOD are 

1 and   . In order to optimise a function, the NLP procedure in SAS® is a 
classic solution.  
 
The estimated parameters were identical from applying either the log-likelihood function (3.6) 
or (3.7). This is because the maximum accrual times were entered as a known part of the 
function in (3.7). In fact, in this step the Negative Binomial distribution was only fitted to the 
numbers of patients recruited in clinical centres. It was, however, the case that the factor of 
accrual time had not been entered in the modelling. The outcome has been summarised in 
table 3.1.  
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   Maximum Likelihood Estimation of frequency data  
Study  ALPHA 
SE-
alpha  BETA  SE-beta 
P= 
1/(1+beta)  mu  SE-mu 
sd of 
data(N
B) 
1  1.273  0.361  12.599  4.286  0.074  16.042  3.015  18.334 
2  3.220  1.641  3.934  2.126  0.203  12.667  2.282  7.905 
3  2.392  0.717  14.125  4.655  0.066  33.791  4.615  22.608 
4  1.280  0.534  3.907  1.896  0.204  5.000  1.238  4.953 
5  2.745  0.977  3.556  1.356  0.220  9.760  1.334  6.668 
6  1.435  0.270  8.402  1.826  0.106  12.061  1.311  10.649 
7  1.417  0.218  7.225  1.271  0.122  10.236  0.875  9.176 
8  1.416  0.198  6.216  0.991  0.139  8.801  0.671  7.970 
9  2.478  0.540  7.334  1.744  0.120  18.176  1.723  12.308 
10  1.314  0.162  10.146  1.462  0.090  13.333  0.995  12.191 
11  1.739  0.252  18.449  3.046  0.051  30.816  2.523  24.979 
12  3.988  1.043  1.826  0.495  0.354  7.280  0.524  4.536 
13  0.995  0.083  16.245  1.699  0.058  16.159  1.016  16.693 
14  1.227  0.095  6.505  0.592  0.133  7.985  0.382  7.742 
15  2.191  1.006  1.567  0.761  0.390  3.433  0.542  2.969 
16  1.070  0.182  5.416  1.096  0.156  5.794  0.636  6.097 
17  0.816  0.214  25.873  8.868  0.037  21.115  4.672  23.821 
18  2.130  0.401  13.270  2.777  0.070  28.267  2.593  20.084 
Table 3.1: Estimated parameters from fitting Negative Binomial to the frequency data  
 
The contour plots of the Maximum likelihood functions with the maximum values of    and 
the probability values p , in which
 

1
1
p , were provided (see appendix 1). The purpose of 
drawing the contour plots was to have a graphical view of the maximum likelihood point of 
both  parameters  in the  function  (figures  3.1).  The  3D  panels  of  the  maximum likelihood 
estimation are also available (see appendix 1).  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  33 
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 Study 7            Study 8 
 
 Study 9           Study 10 
 
 
 Study 11            Study 12 
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Study 13            Study 14 
 
 
Study 15            Study 16 
 
 
Study 17            Study 18 
Figure 3.1: Maximum Likelihood contour plots for parameters in the studies  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  36 
 
3.1.2.2.  Method of Moments 
To capture the parameter estimation from the Method of Moments, the relationship between 
the parameters, mean and variance were considered as follows: 
) ( )) (var(
)) ( (
2
2
x E x
x E

     


E(x)
    
 

1
1
p       (3.8) 
Table 3.2 shows the estimated parameter derived from Method of Moments.  
   Method of moment 
Study  ALPHA  BETA  p 
1  0.799  20.080  0.047 
2  2.415  5.244  0.160 
3  2.608  12.957  0.072 
4  0.822  6.080  0.141 
5  2.059  4.741  0.174 
6  1.454  8.294  0.108 
7  1.505  6.803  0.128 
8  1.216  7.236  0.121 
9  1.949  9.326  0.097 
10  1.176  11.333  0.081 
11  1.384  23.179  0.041 
12  2.651  2.746  0.267 
13  0.413  39.133  0.025 
14  0.827  9.651  0.094 
15  1.428  2.404  0.294 
16  0.532  10.886  0.084 
17  0.886  23.832  0.040 
18  1.826  15.478  0.061 
Table 3.2: Estimated parameters from Method of Moments 
 
Figures 3.2 and 3.3 compare the Maximum likelihood method and Method of moments in 
estimating  the  values  of  the  Negative  Binomial  parameters.  The  Maximum  likelihood 
estimator produces slightly bigger values for the scale parameter   compared to the method 
of moments. However, most of the estimated   values are smaller in Maximum likelihood Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  37 
estimation  method.
 
Figure 3.2: Comparing the Maximum Likelihood Estimation and Method of Moments in estimating shape 
parameter  by fitting Negative Binomial distribution to the frequency data  
 
 
 
Figure 3.3: Comparing the Maximum Likelihood Estimation and Method of Moments in estimating scale 
parameter   by fitting the Negative Binomial distribution to the frequency data 
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3.1.3.  Goodness of fit test (GOF) 
The goodness of fit tests were run to make sure that the Negative binomial model fits well to 
the recruitment data. In fact, this was to measure the discrepancy between the recruitment data 
and the values expected for the Negative Binomial model. These measures were found by the 
Pearson’s chi-square test in SAS.  
The null hypotheses were that the frequency data follow the Negative Binomial distribution. 
To  test  the  hypotheses  the  Pearson  chi-square  values  were  compared  to  a  chi-squared 
distribution. In some of the studies, the test was not significant (table 3.3), which shows that 
the  Negative  Binomial  distribution  has  been  a  suitable  fit  for  the  frequency  domain. 
Nevertheless in one or two trials the fit is clearly far from perfect and this suggests that future 
work could consider alternatives to the NB. 
NB GOF Test in SAS  
Study 
Pearson Chi-Square 
value in GOF test  p-value 
value in chi-sq table  
  01 . 0     df 
1  35.438  0.05  41.638  23 
2  11.692  0.39  24.725  11 
3  19.703  0.66  41.638  23 
4  18.587  0.23  30.578  15 
5  24.977  0.41  42.980  24 
6  64.253  0.50  94.422  65 
7  103.396  0.63  146.257  109 
8  140.383  0.48  181.840  140 
9  55.950  0.26  76.154  50 
10  151.499  0.43  192.073  149 
11  115.603  0.10  132.309  97 
12  71.904  0.55  105.202  74 
13  610.415  0.00  325.881  269 
14  525.943  0.00  478.461  409 
15  27.158  0.56  49.588  29 
16  154.387  0.00  125.290  91 
17  22.171  0.63  44.314  25 
18  63.997  0.31  87.166  59 
Table 3.3: Negative Binomial Goodness of Fit test to the recruitment data (Frequency domain) Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  39 
Drawing the QQ-Plot is a popular graphical approach to assess the suitability of fitting the 
negative Binomial to the frequency data. This is the plot of the quartiles of the negative 
Binomial and the quartiles of the sorted recruitment data. The plot, however, should not be far 
too much away from the straight line (figures 3.4) 
 
Another visual method was also applied to test the goodness of fit for the Negative Binomial 
to the data. The method was to compare the empirical cumulative density function (ecdf) of 
the frequency data and the random values of the Negative Binomial. The two cumulative 
functions should be similar for a good fit (figure 3.4). The graphical GOF test approve that the 
Negative Binomial is a good model for recruitment data in the frequency domain. 
 
Study 1, QQ-plot (left) and the Empirical cumulative density functions (right) 
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Study 2, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
 
Study 3, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
Study 4, QQ-plot (left) and the Empirical cumulative density functions (right) 
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Study 5, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
 
Study 6, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
Study 7, QQ-plot (left) and the Empirical cumulative density functions (right) 
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Study 8, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
 
Study 9, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
Study 10, QQ-plot (left) and the Empirical cumulative density functions (right) 
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Study 11, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
 
Study 12, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
Study 13, QQ-plot (left) and the Empirical cumulative density functions (right) 
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Study 14, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
 
Study 15, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
 
Study 16, QQ-plot (left) and the Empirical cumulative density functions (right) 
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Study 17, QQ-plot (left) and the Empirical cumulative density functions (right) 
 
 
Study 18, QQ-plot (left) and the Empirical cumulative density functions (right) 
Figures 3.4: QQ-Plots and the Empirical cumulative density functions to test the suitability of the Negative 
Binomial to the frequency data. 
 
 
3.1.4.  Discussion 
The unknown parameters  of fitting the Negative Binomial to  the frequency domain were 
estimated. Moreover, the tests show that the Negative Binomial is a suitable model for many 
trials of the recruitment frequency data. However, there are still two main issues to deal with.  
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First is finding a posterior distribution for the recruitment data. This requires an adequate 
knowledge  of  the  true  distribution  of  the  parameters.  However,  there  are  only  estimated 
parameters from the past studies available. Chapter 4 highlights the obstacles of modelling the 
parameters and brings some ideas to deal with the issue.  
 
Second is the accrual time as an effective factor in patient recruitment analysis. The time 
should be considered as a factor that varies from centre to centre. Hence, in chapter 5 the 
accrual time was considered as an offset factor in analysing the recruitment frequency data. If 
the offset time variables are included in the model, the general Negative Binomial model 
remains unchanged although the parameters could be slightly different. In the current chapter, 
it was assumed that all the centres initiate simultaneously. In the case that centres initiate in 
different dates during the trial then the recruitment time would come across to another source 
of variation.  This issue is also solved by adding the start time in simulating the recruitment 
period in chapter 5.  
 
 
 
3.2. Modelling in time domain 
 
Based on the theory that Anisimov & Federov [3] had in their paper, if    N i t ni ,..., 1 ) (  , which 
is the number of patients that are recruited in the clinical centre iup to time t, follow the 
Poisson process with parameter  i   then the total number of patients recruited until time t in Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  47 
all  the  N clinical  centres  is      


N
i
i t n t n
1
 and follows the Poisson distribution with the 
overall rate parameter  

 
N
i
i
1
 .  
Consequently,    N n T , , the length of time to recruit n patients in  N  clinical centres will 
follow  a  Gamma  distribution  with  shape  parameter n  and  scale  parameter    with  the 
probability density function: 
 
1 1 ) , , (
       n T e n T p
n n T                 (3.9)   
in which    n   is the gamma function. Hence, the expected time to recruit  n patients in N
clinical centres is 

n and    2 

n
T Var .  
However, back to the assumption of the distribution of the frequency domain,  i  is a random 
variable  from  a  Gamma  distribution  with  parameters  and   .  Hence,  the  overall  rate 


 
N
i
i
1
 is also Gamma distributed with parameters    , N .  
As  a  result,  the  total  time  to  recruit  patients  has  a  mixture  of  two  independent  Gamma 
distributions and is 
        , , ~ , N Gamma n Gamma N n T             (3.10)  
The above process leads to the Pearson VI distribution with the probability density function 
    
N n
N n
T
T
N n Beta
N n T p 




  



1
,
1
, , , , T>=0          (3.11) 
in which a    N n Beta  ,  is beta function [3]. Therefore, the expected time to recruit n patients 
in  N clinical  centres  will  be 
1  N
n

  and  the  variance  of  the  recruiting  time  is 
 
    2 1
1
2
2
 
 
N N
N n n
 
 
,  2  N  .  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  48 
 
3.2.1  Parameter estimation 
The parameters of the Pearson VI distribution in table 3.4 were estimated by applying the 
Maximum Likelihood Estimation method in SAS and also R. The log-likelihood function of 
the Pearson distribution with the probability function (3.11) is: 
                 
 
       
N
i
i
N
i
i i t N n N t n N n beta N N n t l
1
2
1
log log log 1 , log , , ,         
(3.12) 
 
Maximum Likelihood Estimation of the Time domain 
 
Study  ALPHA  SE-alpha  BETA  SE-beta  E(T)
3 
1  2.260  0.753  1.610  0.540  11.648 
2  0.196  0.004  0.019  0.004  2.159 
3  0.046  0.012  0.009  0.003  73.130 
4  0.396  0.146  0.113  0.044  1.689 
5  0.192  0.054  0.032  0.009  2.019 
6  0.534  0.097  1.142  0.209  26.525 
7  0.024  0.003  0.006  0.001  3.995 
8  0.011  0.001  0.009  0.001  18.568 
9  0.121  0.003  0.039  0.002  6.945 
10  0.174  0.020  0.167  0.020  13.335 
11  0.571  0.083  0.102  0.015  5.820 
12  0.373  0.064  0.260  0.045  5.274 
13  0.024  0.002  0.025  0.002  20.240 
14  0.014  0.001  0.029  0.002  19.720 
15  0.229  0.064  0.996  0.291  17.501 
16  0.045  0.006  0.063  0.010  10.698 
17  0.233  0.064  0.054  0.015  5.849 
18  0.133  0.024  0.081  0.081  19.594 
Table 3.4: Estimated parameters from fitting the Pearson VI distribution to the time domain data 
 
                                                 
3E(T) is the expected length of time (months) to recruit patients in trials with the fixed number of patients based 
on the assumption that the time domain follow the Pearson VI distribution with the estimated parameters.  
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In SAS, the NLP procedure estimated the parameters with the maximum likelihood estimation 
method.  The  parameters  were  also  estimated  in  the  MASS  package  in  R.  The  ‘function’ 
statement was applied for the Pearson VI distribution log-likelihood function then the ‘optim’ 
statement estimated the maximum likelihood of the parameters. The package ‘pearsonDS’ 
also resulted in the similar ML estimation of the parameters.  
 
 
3.3.  Time and frequency parameters correlation test 
It was taken from the theory that the relationship between the Negative Binomial distribution 
and the Pearson VI distribution is similar to the relationship between the Poisson process and 
the Exponential distribution. It means that the parameters    and   in the Poisson-gamma 
mixture are the same as the parameters   and   in the Pearson VI distribution [3]. Hence, it 
was expected that in the completed trials the shape parameter   in the time domain, which 
was estimated from Pearson VI distribution, to be broadly similar to the shape parameter 
estimated  from  Negative  Binomial  distribution  in  frequency  domain.  Also  the  scale 
parameters   are to be very similar in both recruitment domains. Even if the parameters were 
not  similar  due  to  different  parameterisations,  they  were  expected  to  be  strongly  related. 
However, due to difficulty of estimating the parameters from Pearson VI distribution and 
probably because of software issues, the results were not as they were expected. Lack of 
specific option in SAS procedures for Pearson VI distribution could reduce the reliability of 
estimating the parameters. The Pearson VI distribution was hardly a good fit for most of the 
time  data  among  the  18  completed  trials.  More  over  the  frequency  data  were  well  better 
presented than the time data.  
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Nevertheless, the analysis were carried out to draw a scatter plot and run statistical correlation 
test for any possible correlation coefficients between estimated parameters  in frequency 
and  time  domain.  The  scatter  plot  hardly  showed  any  relationship  between  the   values 
(figure 3.5) estimated from Negative Binomial and Pearson VI distribution. 
 
Figure 3.5: Scatter plot of the estimated ALPHA values in Frequency and time domain  
 
Table 3.5 presents the SAS output of the correlation test between the  values in frequency 
domain,  which  were  estimated  from  Negative  Binomial  distribution  and  the  estimated   
values from the Pearson VI distribution in time domain. Based on the calculated p-value (0.63) 
and the 95% confidence correlation limit (-0.5, 0.4) in the Pearson correlation coefficient test, 
the null hypotheses of no correlation between   values could not be rejected.  
 
 
 
 
 
 
Scatter plot of the estimated ALPHA values in the both domains
0.0
0.5
1.0
1.5
2.0
2.5
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
Estimated ALPHA in Frequency domain
E
s
t
i
m
a
t
e
d
 
A
l
p
h
a
 
i
n
 
T
i
m
e
 
d
o
m
a
i
nAndisheh Bakhshi    Supervisor: Prof. Stephen Senn  51 
The CORR Procedure between alpha values 
 
Variable        N          Mean       StdDev        Median       Min           Max 
alpha_freq              18       1.84033       0.85517       1.42600       0.81600       3.98800 
alpha_time             18       0.32178       0.51210       0.19400       0.01100       2.26000 
                    
Pearson Correlation Coefficients, N = 18 
Correlation Estimate=-0.12 
P-value= 0.6316 
 
                    
Pearson Correlation Statistics (Fisher's z Transformation) 
 Variable    With variable  95% Confidence Limits  p Value for H0:Rho=0 
alpha_freq  alpha_time  -0.554176  0.369404  0.6369 
Table 3.5: SAS output of the correlation test between the ALPHA values in Frequency and Time domain 
 
Similar analyses were run to test if the   values estimated in Frequency domain and time 
domain was correlated. The scatter plot hardly illustrates any relationship among   values 
either (figure 3.6).  
 
 
Figure 3.6: Scatter plot of the estimated BETA values in Frequency and time domain  
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The SAS out put of the correlation test between the estimated    values in the Frequency 
domain and the estimated  values in the time domain are displayed in table 3.6.  In the 
CORR procedure the null hypotheses was not rejected within the 95% confidence correlation 
coefficient limit.  
The CORR Procedure between Beta values 
Correlation Estimate = -0.07 
P-value= 0.7169 
               
Pearson Correlation Statistics (Fisher's z Transformation) 
 Variable   
                     With 
variable 
95% Confidence Limits  p Value for H0:Rho=0 
beta_freq  beta_time  -0.523456  0.406185  0.7647 
Table 3.6: SAS output of the correlation test between the BETA values in Frequency and Time domain 
 
 
3.4.  A proposed solution to the time analysis problem 
A logical and practical solution for the issue of analysing the recruitment time was to derive a 
time domain distribution directly from Poisson-gamma process. The application of the first 
principle  of  the  relationship  between  frequency  domain  and  time  domain  is  that  if  the 
frequency domain follows Poisson-gamma mixture, the time to recruit patients will follow the 
Gamma-exponential  mixture.  The  Gamma-exponential  mixture  is  a  special  case  of  the 
Gamma-gamma mixture and it would end up with a similar expression to what Anisimov & 
Federov [3] had in their paper.  
 
For the forecasting purpose, if the patient arrivals are simulated using the Poisson-gamma 
mixture, then the recruitment time are estimated by summing up the individual waiting times 
between patients until the last recruited patient in clinical centres.  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  53 
In the proposed Bayesian based simulation method, a prior distribution had to be found for the 
parameters fitted from the Negative Binomial distribution.  Then, to precede the simulation, 
the posterior mean and variance of the estimated parameters in the frequency domain were 
required as well. The next chapter expands the practical obstacles of modelling the parameters 
for the Bayesian prior distribution.  Finally, in chapter 5 it has been tried to come up with a 
feasible modelling solution for all the analytical issues throughout the research.  
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Chapter 4 
Independence of Model 
Parameters 
 
The key aspect for Bayesian updating was to have a suitable prior distribution of the true 
value of the parameters. However, the uncertainty about the value of the parameters was a 
major issue in forecasting the recruitment. A fundamental assumption was that the parameters 
 and   had to be independent in the frequency domain as well as the time domain so that 
they can be modelled individually. Otherwise, fitting them to a bivariate prior distribution 
could be very complicated.  
 
In this chapter, the independency of the estimated parameters in the recruitment frequency 
domain was tested. Then, regardless of the issues in modelling the time domain (chapter 3), 
the relationship between shape and scale parameters estimated from Pearson VI distribution 
has also been analysed.  
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4.1. Parameters estimated from Recruitment 
frequency domain 
 
A scatter plot was very informative and told most of the story about the relationship between 
parameters. Figure 4.1, illustrates a simple scatter plot and reveals graphically the correlation 
between estimated parameters  and in the recruitment frequency data. 
 
 
Figure 4.1: Scatter plot of estimated   and   from NB distribution in frequency domain 
 
The scatter plot of   and   with their standard errors, however, gave a wider view of the 
relationship  between  parameters.  If it  is  imagined that a  horizontal  whisker illustrates  the 
standard error of   and a vertical line represents the standard error of   through each point 
in the scatter plot, it ends up having something like ‘+’ around each point. As a result, the size 
of each point could indicate how reliable and informative the estimate was. The scatter plot of 
the  shape  parameter   and  the  scale  parameter  ,  which  were  estimated  by  fitting  the 
Negative  Binomial  distribution  to  the  recruitment  frequency  domain,  with  one  standard 
deviation has been visualised in figure 4.2. The green horizontal lines are the standard errors 
of the estimated parameter   and the blue vertical whiskers represent the standard errors of 
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the scale parameter  in clinical trials. Obviously, the points with bigger standard errors are 
less informative and less reliable than others.  
 
Figure 4.2: Scatter plot of  and with 1*SE 
 
The scatter plot in figure 5.2 illustrated only the between-trial correlations between the shape 
and  the  scale  parameters.  Overall,  there  were  within  trial  correlation  coefficients  of  the 
parameters which were negative (table 4.1 and 4.2) and a between trial coefficient that was 
also negative (figure 4.2 & table 4.3). 
 
The  within-trial  correlation  coefficients  displayed  in  table  4.1  were  calculated  in  SAS 
GENMOD procedure while estimating the parameters from fitting the Negative Binomial to 
the recruitment frequency data. This was, however, before taking the accrual time-spans into 
account. The table illustrates that there was quite a strong negative correlation coefficient 
between each pair of    , .  
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Study  ALPHA  BETA 
corr-
coefficient 
1  1.273  12.599  -0.860 
2  3.220  3.934  -0.943 
3  2.392  14.125  -0.910 
4  1.280  3.907  -0.860 
5  2.745  3.556  -0.934 
6  1.435  8.402  -0.866 
7  1.417  7.225  -0.874 
8  1.416  6.216  -0.878 
9  2.478  7.334  -0.917 
10  1.314  10.146  -0.855 
11  1.739  18.449  -0.879 
12  3.988  1.826  -0.964 
13  0.995  16.245  -0.799 
14  1.227  6.505  -0.850 
15  2.191  1.567  -0.946 
16  1.070  5.416  -0.840 
17  0.816  25.873  -0.764 
18  2.130  13.270  -0.899 
Table 4.1: Estimated values of parameters from Negative Binomial and within trial correlation coefficient 
 
It is also evidenced from the SAS output, which is displayed in table 4.2, that the mean of the 
within trial correlation coefficient in the frequency domain was not zero under the default 95% 
confidence limit.  
 
The SAS System 
The UNIVARIATE Procedure 
Within-trial   correlation coefficient (alpha vs beta in each trial) 
 N                          18     Sum Weights                 18 
Mean                    -0.88    Sum Observations       -15.84 
Std Deviation       0.051    Variance                           0.003 
Skewness              0.40    Kurtosis                             0.24 
Uncorrected SS  13.98    Corrected SS                     0.04 
Coeff Variation   -5.85                              Std Error Mean                0.012 
Tests for Location: Mu0=0 
Test  -Statistic-  -----p Value------ 
Student's t  t  -72.4724  Pr > |t|    <.0001 
Sign  M  -9  Pr >= |M|   <.0001 
Signed Rank  S  -85.5  Pr >= |S|   <.0001 
Table 4.2: SAS output for the location test of the within trial correlation between parameters in frequency 
domain 
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The negative between trial correlations coefficient in the frequency domain has also been 
statistically  documented  in  the  SAS  CORR  procedure  in  table  4.3.  The  between  trial 
correlation were calculated between the two vectors of the estimated parameters.  
 
      The SAS System          
    
The CORR Procedure 
Between-trial correlation coefficient 
(Between the vectors of alpha and 
beta)        
                 
      2  Variables:   ALPHA       BETA        
Variable           N          Mean       Std Dev        Median       Minimum       Maximum 
ALPHA          18       1.84033       0.85517       1.42600       0.81600       3.98800 
 BETA            18       9.25528       6.44033       7.27950       1.56700      25.87300 
P_value = 0.0456  
                      
Table 4.3: SAS output of the between correlation coefficient of parameters among all the trials in the 
frequency domain 
 
It  was  clear  from  the  analysis  that  there  were  strong  negative  correlations  between  the 
parameters    and    that  were  estimated  from  Negative  Binomial  distribution  in  the 
recruitment  frequency  data.  This  implied  that  the  parameters  could  not  be  modelled 
individually as a prior distribution for the Bayesian update. Therefore, the question raised here 
was whether a particular parameterisation could be found to make the estimates of   and 
independent in some level. In this case, the new parameters had to be estimated and modelled 
for all the trials.  
 
4.2. Parameter estimation from recruitment time 
domain 
 
Despite  the  issue  of  incomparability  of  modelling  the  time  domain  from  Pearson  VI 
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put under assessment. The scatter plots in figure 4.3 & 4.4 and also the statistical tests in table 
4.5 revealed that the estimated parameters are highly correlated inside the trials. This time, 
however, the correlation coefficients between the shape and the scale parameters are strongly 
positive. 
 
 
Figure 4.3: Scatter plot of Alpha and beta in time domain 
 
Opposite  the  frequency  domain,  the  estimated  parameters  in  the  time  domain  were  less 
scattered and more informative. This was due to the smaller standard errors for each point 
(figure 4.4). Although the parameters estimated in the recruitment time data seemed to be 
more reliable, the quality of data provided in the frequency domain was more suitable for 
modelling patient recruitment.  So, it is still aimed to analyse the recruitment time by moving 
from frequency domain to time domain.  
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Figure 4.4: Scatter plot of ALPHA and BETA estimated from Pearson VI distribution with 1*Standard 
Deviation 
 
The within trial correlation coefficients in table 4.4 were estimated in SAS NLP procedure 
after  each  Pearson  VI  parameter  were  estimated.  The  location  test  for  the  within  trial 
correlation coefficient has been summarised in table 4.5, which shows a strong positive value 
of 0.87.  
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Study  ALPHA  BETA  corr-coefficient 
1  2.260  1.610  0.996 
2  0.196  0.019  0.146 
3  0.046  0.009  0.798 
4  0.396  0.113  0.964 
5  0.192  0.032  0.950 
6  0.534  1.142  0.993 
7  0.024  0.006  0.909 
8  0.011  0.009  0.853 
9  0.121  0.039  0.420 
10  0.174  0.167  0.991 
11  0.571  0.102  0.996 
12  0.373  0.260  0.992 
13  0.240  0.025  0.962 
14  0.014  0.029  0.958 
15  0.229  0.996  0.969 
16  0.045  0.063  0.942 
17  0.233  0.054  0.960 
18  0.133  0.081  0.969 
Table  4.4:  Estimated  values  of  parameters  from  Pearson  VI  distribution  and  within  trial  correlation 
coefficient  
 
The SAS System    
 The UNIVARIATE Procedure    
Within-trial correlation coefficient 
(Between alpha and beta values in each trial)    
              
                                             Moments      
N                          18      Sum Weights                 18    
Mean                    0.88  Sum Observations        15.77    
Std Deviation      0.23  Variance            0.05    
Skewness            -2.68   Kurtosis            6.81    
Uncorrected SS      14.69  Corrected SS          0.87    
Coeff Variation    25.88  Std Error Mean      0.05    
              
                                    Tests for Location: Mu0=0    
 Student's t              Pr > |t|    <.0001 
Signed Rank              Pr >= |S|   <.0001 
Table 4.5: SAS output for the location test of the within trial correlation between parameters in time 
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The CORR procedure output, which is displayed in table 4.5, proved that there was also a 
high correlation-coefficient between the trials in time domain. The correlation of the between 
trial parameters was also positive.  
 
The SAS System 
The CORR Procedure 
Between-trial correlation coefficient  
(Between the vectors of alpha and beta) 
2  Variables:   ALPHA        BETA 
Simple Statistics 
    Variable               N          Mean       Std Dev        Median       Minimum       Maximum 
ALPHA                 18       0.32178       0.51210       0.19400       0.01100       2.26000 
BETA                18       0.26422       0.47081       0.05850       0.00600       1.61000 
                 
Pearson Correlation Coefficients, N = 18 
P_value = .0001        
                
Table 4.6: SAS output of the between correlation coefficient of parameters among all the trials in the time 
domain 
 
 
 
 
4.3. Discussion 
In the previous chapter it was decided to analyse the recruitment by moving smoothly from 
the recruitment frequency data to the time domain. This required the frequency parameters to 
be estimated and the distribution of the true parameters were to be found. Nevertheless, as it 
was highlighted formerly, the two Negative Binomial parameters had to be independent. In 
the  next  step,  the  issue  was  addressed  by  including  the  time  spans  into  modelling  the 
frequency  domain.  Simultaneously,  two  other  parameters  were  estimated  by  fitting  the 
Negative  Binomial  distribution  to  the  recruitment  frequency  data.  Therefore,  the  new Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  63 
independent parameters could be modelled individually to find a suitable prior distribution for 
the frequency data.   
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Chapter 5 
Transformations and Predictions 
 
5.1. Issues in modelling and solutions 
The  modelling  and  predicting  process  came  across  several  issues,  some  of  which  were 
covered in previous chapters. In chapter 3, the shape parameters  and scale parameters  
were estimated by fitting the Negative Binomial distribution to the recruitment frequency data 
only      , ~ NB x . The frequency scale was later found to be broadly compatible when the 
time-spans of patient recruitment were included in the modelling. This update was applied by 
using ‘offset’ option in SAS modelling procedures. The offset variable was equalled to the 
patients’ accrual time (the time unit was set to months throughout the research) in centres, 
which considered the time as a fixed factor in the null regression model.  
 
The second problem appeared when the estimated parameters in the time domain (chapter 3) 
were far different from the theoretical expectations. Hence, the data that were provided were 
really  only  suitable  for  modelling  the  frequency  domain,  but  the  time  domain  was  more 
important for practical forecasting. This issue was addressed by simulating the frequency data 
in the Poisson-gamma process and generating the waiting time between patients from the 
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The  dependency  of   and    especially  in  the  frequency  domain  made  the  business  of 
applying Bayesian methods more complex. Hence, it was not feasible to treat them as if they 
are  independent  for  handling  forecasting.  Therefore,  a  transformation  of  parameters  was 
desirable  to  make  them  independent  [18].  To  deal  with  the  problem,  two transformed 
parameters 

1
 k and     , were considered for the estimation instead of   , .  
 
To apply the Bayesian forecasting methods properly, further data of individual recruitment 
dates were required. The forecasting approach for waiting time between patients and also the 
length  of  time  required  to  accrue  patients  in  clinical  centres  were  finally  illuminated  by 
applying the simulation method using a Poisson-gamma and Gamma- exponential mixture.  
 
 
5.2. Parameter estimation 
In  addition  to  estimating  two  different  parameters  by  fitting  the  Negative  Binomial 
distribution  (equation  3.3)  to  the  recruitment  frequency  data,  the  time-spans  have  been 
included  in  the  model  by  using  ‘offset’  option  in  Genmod  procedure  in  SAS.  The  new 
parameters were the dispersion parameter, which is

1
 k  and the mean parameter which is in 
fact    ;  is the parameter representing the mean number of recruited patients per centre 
in the trial.  
 
The GENMOD procedure in SAS® was applied to estimate the new parameters using the 
method of maximum likelihood. The results are displayed in table 5.1.  The values of the 
estimated parameters are slightly different from the estimated parameters in table 3.1, which Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  66 
is due to including recruitment time into the Negative Binomial parameter estimation using 
‘offset’ option.  
 
Study  n 
K = 
1/ALPHA= 
dispersion  SE (K) 
within trial 
variance (k)  mu 
SE 
(mu) 
within trial 
variance (mu) 
1  385  0.789  0.238  0.057  13.658  3.026  9.155 
2  152  0.274  0.145  0.021  11.838  2.138  4.569 
3  811  0.406  0.122  0.015  30.960  4.522  20.451 
4  80  0.673  0.295  0.087  4.065  1.109  1.229 
5  244  0.351  0.127  0.016  9.088  1.304  1.701 
6  796  0.687  0.130  0.017  8.679  1.296  1.680 
7  1126  0.678  0.106  0.011  8.884  0.847  0.718 
8  1241  1.000  0.135  0.018  8.802  0.671  0.451 
9  927  0.395  0.087  0.007  16.187  1.700  2.889 
10  2000  0.754  0.093  0.009  10.669  0.988  0.975 
11  2936  0.574  0.083  0.007  30.304  2.521  6.353 
12  546  0.250  0.065  0.004  5.634  0.523  0.273 
13  4363  0.986  0.083  0.007  12.882  0.995  0.991 
14  3274  0.781  0.061  0.004  4.851  0.369  0.136 
15  103  0.528  0.227  0.051  0.903  0.569  0.324 
16  533  0.894  0.154  0.024  3.367  0.610  0.372 
17  549  1.226  0.321  0.103  19.475  4.675  21.859 
18  1696  0.469  0.088  0.008  25.364  2.592  6.721 
Table 5.1: Estimated transformed parameters from fitting Negative Binomial to the frequency data and 
including time-spans to the model 
 
 
 
5.3. Correlation test for the transformed 
parameters in frequency domain 
 
The transformation of the estimated parameters was beneficial only if the parameters end up 
being  independent.  In this  case, it is  possible to model them individually to  find a prior Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  67 
distribution for the parameters. There were two approaches to look at independence. The first 
was combining the evidence from each trial as regards the within-study correlation test. The 
second was examining the pairs of parameter estimates from each trial to look at the between 
trial  correlation.  It  is  clear  from  table  5.2  that  the  within-study  correlation  coefficients 
between the estimated values of parameters    , k  are remarkably reduced compared to the 
correlation coefficient between  and   in table 4.1. Of course, including an offset might in 
any case produce some change but this is not the explanation here.   
 
Study  n 
1/ALPHA= 
k= dispersion  mu 
corr-coefficient    
(k & mu)  cov  (k & mu) 
1  385  0.789  13.658  0.0002  0.00013 
2  152  0.274  11.838  -0.0101  -0.00313 
3  811  0.406  30.960  -0.0010  -0.00054 
4  80  0.673  4.065  -0.0234  -0.00765 
5  244  0.351  9.088  -0.0024  -0.00040 
6  796  0.687  8.679  -0.0009  -0.00015 
7  1126  0.678  8.884  -0.0029  -0.00026 
8  1241  1.000  8.802  0.0000  0.00000 
9  927  0.395  16.187  -0.0011  -0.00016 
10  2000  0.754  10.669  -0.0005  -0.00005 
11  2936  0.574  30.304  0.0000  -0.00001 
12  546  0.250  5.634  -0.0001  0.00000 
13  4363  0.986  12.882  -0.0009  -0.00008 
14  3274  0.781  4.851  -0.0038  -0.00009 
15  103  0.528  0.903  0.0306  0.00395 
16  533  0.894  3.367  -0.0055  -0.00051 
17  549  1.226  19.475  0.0000  0.00002 
18  1696  0.469  25.364  0.0000  0.00000 
Table 5.2: Table of the correlation-coefficient and covariance between estimated parameters k and mu 
from Negative Binomial with adding time-spans in the model 
 
 Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  68 
As regards the first matter, the statistical correlation test between parameters    , k  in trials 
suggested that it was possible to treat them as two independent parameters. Table 5.3 tests the 
18 within-study correlation coefficients to see if there is any evidence that on average they are 
different from zero. The summary of results is displayed below. 
 
 
The SAS System  
                                     The UNIVARIATE Procedure    
                                          Variable:  corr 
          (Within-trial correlation coefficient between k and mu)      
                                    Tests for Location: Mu0=0 
p Value= 0.6057 
 
Table 5.3: SAS output of the within trial correlation coefficient test between parameters k & mu 
 
The second matter was also addressed by testing the independence between pairs of estimated 
parameters in  trials.  The Pearson correlation  coefficient  test  (table 5.4) did  not  reject  the 
independence of the parameters among the trials either, which meant that two issues have 
been solved simultaneously. Adding the time-spans (accrual time) into the Negative Binomial 
model tuned the estimations into more compatible results. At the same time, a transformation 
in parameters made them independent from each other.  
The SAS System  
 The CORR Procedure 
Between-trial correlation coefficient 
2  Variables:    k        mu 
Simple Statistics 
Variable           N          Mean       Std Dev           Sum        
            k             18       0.65            0.27               11.71            
           mu           18      12.53          8.87                225.61        
                    
                             Pearson Correlation Coefficients 
     P_value=  0.6604  
Table 5.4: SAS output of the correlation test between parameters k & mu among the trials 
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5.4. Prior distribution of parameters 
Based on the literature review, the most feasible marginal distribution for the recruitment 
frequency data was the Negative Binomial distribution. Then, to proceed to the Bayesian 
prediction method, the true values of the parameters were to be modelled. The true values are 
different from what would be estimated. The true parameters are what are observed if each 
trial had an infinitive number of centres with an infinitive number of patients. Because this is 
not the case, the variability of the observed parameters is bigger than the true parameters. In 
addition to that, the initial parameters    and    were  previously  found  to  be  dependent. 
Hence,  the  transformed  parameters k  and   were  considered  for  the  maximum  likelihood 
estimation.  
 
The  parameters  k  and   were  modelled  individually  to  see  if  they  follow  the  Normal 
distribution. The Normal distribution although not ideal could be a suitable approximate prior 
distribution for the Negative Binomial parameters given an appropriate transformation of the 
parameters.  If  the  Normal  distribution  was  a  good  fit  for  parameters,  then  estimating  the 
posterior values of the parameters would be easier. The result of testing how well the Normal 
distribution fits to the to the Negative Binomial parameters  k  and   showed that it was a 
practical fit. The SAS univariate outputs are displayed in table 5.5 for the parameter k and 
table 5.6 for . All the three statistical GOF tests approved the assumptions of the Negative 
Binomial parameters following the Normal distribution.  
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The SAS System 
The UNIVARIATE Procedure 
Fitted Distribution for k 
  
Parameters for Normal Distribution 
Parameter   Symbol   Estimate 
Mean        Mu       0.651 
StdDev     Sigma    0.271 
  
Goodness-of-Fit Tests for Normal Distribution 
Test                  -----p Value----- 
Kolmogorov-Smirnov   >0.150 
Cramer-von Mises      >0.250 
Anderson-Darling      >0.250 
Table 5.5:  SAS output of the normality test of the parameter k 
 
The SAS System 
The UNIVARIATE Procedure 
Fitted Distribution for mu 
  
Parameters for Normal Distribution 
Parameter   Symbol   Estimate 
Mean        Mu       12.53 
StdDev     Sigma    8.87 
  
Goodness-of-Fit Tests for Normal Distribution 
Test                  -----p Value----- 
Kolmogorov-Smirnov   >0.150 
Cramer-von Mises      0.065 
Anderson-Darling      0.051 
Table 5.6: SAS output of the normality test of the parameter mu  
 
The normality test was also run for Ln(k). It was to apply Ln (k) instead of k in the simulation 
process  in  order  to  avoid  generating  negative  k  values.  The  parameter  k  in  the  Negative 
Binomial  distribution  gets  positive  values  only.  However,  the  estimated  values  of  the 
parameter k could get negative values in the process of generating the Normal distribution. 
For that reason, the parameter Ln (k) was initially applied. There was no such consideration Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  71 
for parameter   since its mean was big enough compared to its standard deviation in each 
trial.  
 
The SAS System 
The UNIVARIATE Procedure 
Fitted Distribution for Ln_k 
  
Parameters for Normal Distribution 
Parameter   Symbol   Estimate 
Mean        Mu       -0.51 
StdDev     Sigma    0.43 
  
Goodness-of-Fit Tests for Normal Distribution 
Test                  -----p Value----- 
Kolmogorov-Smirnov                         >0.150 
Cramer-von Mises                              >0.250 
Anderson-Darling                               >0.250 
Table 5.7: SAS output of the normality test of Ln (k)  
 
Among all the 18 completed trials, one trial was chosen to illustrate the calculation of the 
posterior distribution. The prediction process relied on the posterior values of the selected trial. 
To  calculate  the  posterior  values  of  the  trial  it  was  necessary  to  estimate  the  variances 
between  the  18  completed  trials.  In  theory  the  relationship  between  the  variances  of 
parameters is:  
Total variance = between trial variance + within trial variance        (5.1) 
The within trial variances for parameters k and   (displayed in table 5.1 and table 5.8) were 
estimated in the SAS GENMOD procedure in Fitting the Negative Binomial distribution to 
the frequency data. The within trial variances for Ln (k), however, were calculated using the 
equation:  
      k
k
k var
1
ln var
2                    (5.2) Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  72 
The above is an approximate formula based on Taylor’s expansion of  Ln(k) using the so-
called ‘delta method’.  
 
Study  mu  SE (mu) 
within trial 
variance 
(mu)  Ln_k  Se (Ln_k) 
within trial 
variance 
(Ln_k) 
1  13.658  3.026  9.155  -0.237  0.302  0.091 
2  11.838  2.138  4.569  -1.295  0.529  0.280 
3  30.960  4.522  20.451  -0.902  0.301  0.091 
4  4.065  1.109  1.229  -0.396  0.439  0.193 
5  9.088  1.304  1.701  -1.048  0.361  0.130 
6  8.679  1.296  1.680  -0.376  0.189  0.036 
7  8.884  0.847  0.718  -0.389  0.156  0.024 
8  8.802  0.671  0.451  0.000  0.134  0.018 
9  16.187  1.700  2.889  -0.929  0.219  0.048 
10  10.669  0.988  0.975  -0.282  0.123  0.015 
11  30.304  2.521  6.353  -0.555  0.145  0.021 
12  5.634  0.523  0.273  -1.388  0.262  0.069 
13  12.882  0.995  0.991  -0.014  0.084  0.007 
14  4.851  0.369  0.136  -0.247  0.078  0.006 
15  0.903  0.569  0.324  -0.638  0.429  0.184 
16  3.367  0.610  0.372  -0.112  0.172  0.030 
17  19.475  4.675  21.859  0.204  0.262  0.069 
18  25.364  2.592  6.721  -0.756  0.188  0.035 
Table 5.8: Estimated parameters mu and Ln (k) with their within-trial standard errors and variances 
 
The  observed  (total)  variance  of  the  parameters  could  be  calculated  while  modelling  the 
parameters  as  a  normal  distribution.  From  table  5.5  the  total  variance  of  parameter  k  is 
  073 . 0 271 . 0
2  , based on table 5.6 the total variance of parameter   is   730 . 78 873 . 8
2 
and according to the table 5.7 the total variance of parameter Ln (k) is   187 . 0 433 . 0
2  .  
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5.5. Random Effect meta-analysis [19, 20] 
The general purpose of meta-analysis is to estimate the true effect size of the parameters taken 
from  a  study  under  special  assumptions  and  conditions.  The  meta-analysis  combines  the 
results of the completed trials and gives the effect size of the parameters as its output. Since 
the  parameters  are  independent,  the  one  dimensional  random  effect  analysis  would  work 
efficiently. That is to say, a separate meta-analysis was applied to both Ln (k) and  .  
 
The random effect meta-analysis macro in SAS [19,20] takes the estimated values as well as 
the estimated within-trial standard deviations of the parameter in all trials and calculates the 
posterior estimation of the parameter based on the normal distribution. It also estimates the 
random effect variance of the parameter. The result of the random effect meta-analysis of 
parameters k, Ln (k) and   are summarised in tables 5.9, 5.10 and 5.11 respectively. The 
posterior variances of the parameters, however, were calculated based on the assumption of 
normal distribution of parameters and applying the equation: 
iance trial within Variance E R
iance Posterior
var . .
1
. .
1
1
var .

         (5.3) 
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Meta-analysis, Der Simonian& Laird method 
Study 
1/ALPHA= 
k= 
dispersion 
within trial 
variance (k) 
Posterior estimation 
of k 
Posterior 
variance of k 
1  0.789  0.057  0.707  0.028 
2  0.274  0.021  0.372  0.015 
3  0.406  0.015  0.453  0.012 
4  0.673  0.087  0.645  0.034 
5  0.351  0.016  0.413  0.012 
6  0.687  0.017  0.673  0.013 
7  0.678  0.011  0.669  0.009 
8  1.000  0.018  0.908  0.014 
9  0.395  0.007  0.423  0.007 
10  0.754  0.009  0.737  0.007 
11  0.574  0.007  0.580  0.006 
12  0.250  0.004  0.277  0.004 
13  0.986  0.007  0.946  0.006 
14  0.781  0.004  0.772  0.003 
15  0.528  0.051  0.576  0.027 
16  0.894  0.024  0.813  0.017 
17  1.226  0.103  0.835  0.036 
18  0.469  0.008  0.489  0.007 
Estimated mean of k from meta-analysis  0.627 
R.E Variance of the parameter k  0.055 
Table 5.9: SAS results of the random effects meta-analysis for parameter k 
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Meta-analysis, Der Simonian& Laird method 
Study  Ln_k 
within trial 
variance (Ln_k) 
Posterior estimation 
of Ln_k 
Posterior 
variance of 
Ln_k 
1  -0.237  0.091  -0.342  0.044 
2  -1.295  0.280  -0.642  0.066 
3  -0.902  0.091  -0.665  0.044 
4  -0.396  0.193  -0.427  0.059 
5  -1.048  0.130  -0.682  0.052 
6  -0.376  0.036  -0.395  0.025 
7  -0.389  0.024  -0.400  0.019 
8  0.000  0.018  -0.076  0.015 
9  -0.929  0.048  -0.754  0.031 
10  -0.282  0.015  -0.306  0.013 
11  -0.555  0.021  -0.532  0.017 
12  -1.388  0.069  -0.967  0.038 
13  -0.014  0.007  -0.047  0.007 
14  -0.247  0.006  -0.260  0.006 
15  -0.638  0.184  -0.504  0.059 
16  -0.112  0.030  -0.197  0.022 
17  0.204  0.069  -0.082  0.038 
18  -0.756  0.035  -0.664  0.025 
Estimated mean of Ln(k) from meta-analysis  -0.441 
R.E Variance of parameter Ln(k)  0.086 
Table 5.10: SAS results of the random effects meta-analysis for parameter Ln (k) 
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Meta- analysis , Der Simonian& Laird method 
Study  mu 
within trial 
variance (mu) 
Posterior estimation 
of mu 
Posterior 
variance of mu 
1  13.658  9.155  12.921  6.300 
2  11.838  4.569  11.739  3.726 
3  30.960  20.451  21.066  10.163 
4  4.065  1.229  4.475  1.159 
5  9.088  1.701  9.261  1.569 
6  8.679  1.680  8.880  1.551 
7  8.884  0.718  8.963  0.693 
8  8.802  0.451  8.854  0.441 
9  16.187  2.889  15.577  2.527 
10  10.669  0.975  10.699  0.930 
11  30.304  6.353  25.751  4.833 
12  5.634  0.273  5.705  0.269 
13  12.882  0.991  12.806  0.944 
14  4.851  0.136  4.893  0.135 
15  0.903  0.324  1.064  0.319 
16  3.367  0.372  3.513  0.365 
17  19.475  21.859  15.225  10.499 
18  25.364  6.721  21.849  5.043 
Estimated mean of mu from meta-analysis  11.291 
R.E Variance of the parameter mu  20.202 
Table 5.11: SAS results of the random effects meta-analysis for parameter mu 
 
 
 
5.6. Posterior estimations for the selected trial 
The Bayesian prediction method was applied on one completed trial. The chosen trial had 
special information that was essential for the forecasting process.  The study included the 
details  about  the  individual  recruitment  date  as  well  as  each  centre’s  activation  date. 
Therefore, the waiting time between patients in the whole trial was available. The trial had 
recruited 152 patients in 12 centres in just less than 4 months.  
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The trial, then, was  monitored in  four different time intervals.  After each interval  a new 
dataset was produced and the Negative Binomial parameters in the frequency domain were 
estimated for every new data set. The first dataset included the number of patients that had 
been recruited by the first month after the first centre had been activated. The second data 
sheet had the details about the patients in clinical centres just 2 months after the first site had 
been activated. In the third data set, there was the number of patients that were recruited by 
the third month of the start of the trial.  Finally the last data set contained the total recruitment 
details of the trial by the time it had finished, when all the clinical centres had entered the trial. 
There were 4 data sets in total and the parameters were estimated by fitting the Negative 
Binomial distribution to the frequency domain.    
 
The recruitment had not initiated simultaneously in all centres. In other word, the clinical 
centres had been activated in different dates. Consequently, in each data set, the recruitment 
times varied among centres and depend on the activation date.  The clinical centres were 
added to the datasets one by one. Only the fourth data set included all the centres in the trial.   
 
Table 5.12 illustrates the number of patients that had been recruited in the clinical centres as 
well as their accrual time in the four data sets. 
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By the end of the 
1
st month (15/04/) 
By the end of the 
2
nd month (15/05/) 
By the end of the 
3
rd  month (15/06/) 
BY the end of the 
trial (15/07/) 
site 
site 
activation 
date  patients 
Accrual 
time-
month  patients 
Accrual 
time-
month  patients 
Accrual 
time-
month  patients 
Accrual 
time-
month 
1  15/03/  6  0.99  14  1.89  23  3.05  26  3.36 
2  16/03/  2  0.89  5  1.79  6  2.52  6  2.52 
3  16/03/  1  0.89  5  1.83  12  3.03  18  3.89 
4  16/03/  7  0.99  18  1.90  25  3.03  28  3.79 
5  30/05/              1  0.46  10  1.49 
6  23/06/                    11  0.70 
7  30/05/                    2  1.42 
8  19/04/        4  0.80  5  1.44  6  2.37 
9  19/04/        1  0.73  5  1.89  6  2.76 
10  19/04/        2  0.79  5  1.19  9  2.86 
11  19/04/        3  0.76  10  1.66  17  2.77 
12  06/06/              4  0.29  13  1.27 
Patientsrecruited 
16 
    
52 
    
96 
    
152 
    
Average 
recruitment per 
centre per month  4.00     3.25     3.20     3.25    
Table 5.12: The four recruitment data set made from the selected trial in four time intervals monitoring 
 
In the next step the posterior mean values and the posterior variances of the parameters were 
calculated in all the four data sets derived from the trial.  
The posterior estimations of the parameters were based on the assumption that the parameters 
follow the normal distribution. Equation (5.3) was applied to calculate the posterior variances 
of the parameters.  
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Estimated parameters and the posterior values 
   1
st data set  2
nd data set  3
rd data set  4
th data set 
number of patients  16  52  96  152 
parameter k  0.187  0.463  0.423  0.290 
se (k)  0.339  0.301  0.233  0.151 
within trial variance (k)  0.115  0.090  0.054  0.023 
Ln_k  -1.675  -0.770  -0.860  -1.239 
se (Ln_k)  1.810  0.650  0.551  0.520 
within trial variance 
(Ln_k)  3.278  0.422  0.303  0.271 
Posterior estimation 
(Ln_k)  -0.473  -0.497  -0.534  -0.633 
Posterior variance ( Ln_k)  0.084  0.071  0.067  0.065 
parameter mu (estimated 
mean number of patients 
in centres after each 
interval) 
4.016  5.854  8.501  11.667 
Estimated mean number of 
patients per centre per 
month (mu/time interval) 
4.02  2.93  2.83  2.99 
se (mu)  1.318  1.742  2.119  2.199 
within trial variance (mu)  1.737  3.033  4.490  4.836 
posterior estimation (mu)  4.592  6.564  9.009  11.595 
Posterior estimation of the 
average recruitment per 
centre per month (mu/time 
interval) 
4.59  3.28  3.00  2.97 
posterior variance (mu)  1.599  2.637  3.674  3.902 
Table 5.13: Summary of the estimated parameters and the posterior values for the selected trial in four 
time intervals 
 
The posterior mean of the parameters were calculated from substituting the values in the 
equations (5.4) and (5.5).  
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In calculating the posterior values,  (.) . .
2  E R is the random effect variance of the parameters 
among the 18 completed trials and  (.) mean is the estimated mean of the parameters in the 
trials derived from meta-analysis. The   . . .
2  trial within , in the second part of the equations, is 
the within  trial variance of the parameter, which was  estimated from  fitting the Negative 
Binomial distribution to the frequency data. The estimated parameters in the four time interval 
data sets and the within trial variances of the parameters are displayed in table (5.13).  
 
 
5.7. Prediction of patient recruitment 
The aim of the current simulation was to use the data from completed trials in the frequency 
domain and forecast the patient recruitment in the time domain in multi-centre clinical trials. 
In practice, predicting the accrual time for the pre-arranged sample size was more important 
than predicting the number of patients in the clinical trials. However, the data provided was 
more suitable for working on the frequency domain. This research, however, managed to 
simulate the patients accrual times (in month) in an on-going trial by using the frequency 
domain in completed trials.  
 
Regarding the prediction approach, it was to look at the predictions that were estimated from 
the trial simulations and compare them with the real trial.  
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In section 5.7.1 we discuss the theoretical problem of predicting how long it would take to run 
a second 152 patient trial given the information available at month 1, 2, 3 and 4. For example, 
suppose we need to conduct a second similar trial for regulatory submission to satisfy the 
regulatory needs of replication. If the planning phase occurs whilst the initial study is going 
on, we investigate how long it will take to recruit 152 patients in a new study using the 1, 2 
and 3 month data. The more interesting practical question of concern is how long it will take 
to complete the on-going trial which is discussed in section 5.7.2. That is, at month 1 how 
long will it take to recruit the additional 136 patients, at month 2 how long will it take to 
recruit the additional 100 patients etc. 
 
The predictions were run 1000 times in R version 2.12.1. The simulations were initially based 
on the posterior information of the four datasets derived from the selected trial.  
 
The selected trial had recruited 152 patients in 12 clinical centres. In order to make a similar 
trial, N=12 clinical centres were simulated for the trial. However, taking the safe side, 152 
individuals  were  simulated  for  each  centre,  which  makes  a  trial  of  n=12*152  patients. 
Although  n=152  patients  of  the  whole  trial  would  be  used  only.    It  did  not  affect  the 
predicting process since the n patients are considered by the order they arrived to the trial 
regardless of the centres.  
 
 
5.7.1.  Prediction in the frequency domain 
Each centre had one pair of estimated parameters    ), ln(k  and it was supposed that they 
follow the Normal  distribution.  Hence,  for  each  data  set,  the  simulation  approach  was  to Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  82 
generate N=12 random values of  ) ln(k and   with the estimated posterior mean values and 
posterior variances displayed in table (5.13). Random values of k were derived by taking 
exp(ln(k)) from the generated  ) ln(k .  
 
The next step for the four data sets was to generate n=152 random numbers (patients) from 
the Negative  Binomial  distribution  with  the parameters (k ,  )  generated  for  each  centre. 
Although, the total number of patients in the whole trial was 152, this amount was generated 
for each centre to be able to predict recruitment time for a second trial of the same size. So far 
the simulated trials of the four data sets have produced matrices of N=12 rows (centres) and 
n=152  frequencies,  which  represented  the  number  of  patients  that  have  been  recruited  in 
clinical centres. Consequently, the overall mean of each matrix divided by their monitoring 
interval times gave the mean number of patients per centre per month in the simulated trial.    
 
According to the data set collected by the end of 1
st month of the trial (table 5.12), 4 patients 
in average were recruited in each centre during the first month of the trial.  When the trial 
went on to its second month four new centres were activated as well as more patients were 
recruited. But the average number of patients reduced to 3.25 per centre per month. Another 
slight reduction of 0.05 in the average number of recruited patients appeared by the end of 3
rd 
month. The average number of accrued patients per centre per month slightly recovered to 
reach to 3.62 by the end of the trial. Figure 5.1 illustrates the average recruitment trend per 
centre per month in the completed trial.  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  83 
Figure 5.1: Line graph of the average number of recruited patients per centre per month in the completed 
trial througout the four monitoring intervals. 
 
Figure 5.2 shows the histogram of the predicted average number of patients per centre per 
month based on the one-month information simulated trial. The histogram says that having 
had the recruitment data of the first month only, it is expected to recruit the average number 
of  4.09  to  5.13  (95%  CI:  4.43-5.04)  patients  per  centre  per  month  throughout  the  trial. 
Although the value of the real trial is very close to the lower band of the histogram, the 95% 
confidence interval does not cover the values of the real trial. It means that the simulated trial 
has slightly over estimated the recruitment.  
1st month 2nd month 3rd month end of trial
Average number of patients 
per centre per month 4 3.25 3.2 3.25
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Figure 5.2: Average number of recruited patients per centre per month based on one month monitoring 
 
The prediction on the frequency domain changed slightly after the trial finished the second 
month of recruiting patients. Based on the two months information in an on-going trial, the 
simulated average number of patients was a number between 3.02 and 3.73 (95% CI: 3.13-
3.57) patients per centre per month (Figure 5.3). The prediction is perfectly matched to the 
values of the completed trial.  
 
Simulated mean number of patients per centre per month based on one-month information of the example completed trial
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Figure 5.3: Average number of recruited patients per centre per month based on two months monitoring 
 
 
The expected frequency of patients per centre per month is predicted to be between 2.71 and 
3.60  (95%  CI:  2.90-3.31)  based  on  the  simulated  trial  of  the  three-month  data  set  in  an 
ongoing trial (figure 5.4).  The confidence interval included the average value of the real trial 
in the third data set (3.20) as well as the last data set (3.24).  
Simulated mean number of patients per centre per month based on two-month information of the example completed trial
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Figure 5.4: Average number of recruited patients per centre per month based on three months monitoring 
 
By the end of the trial, the average number of patients per centre per month in the example 
trial were about  3.25.  It was  located inside the 95% confidence interval  of the predicted 
average number of patients. In the simulated trial,derived after the trial ended, the expected 
range was between 2.60 and 3.39 (95% CI: 2.80-3.27). The histogram of the final simulation 
is displyed in figure 5.5.  
Simulated mean number of patients per centre per month based on three-month information of the example completed trial
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Figure 5.5: Average number of recruited patients per centre per month based on four months monitoring 
Figure 5.6 illustrates a visual comparison between the average number of recruited patients 
per centre per month in the simulated trials and the real completed trial as well as the marginal 
and posterior estimation in different time intervals. The values of the observed data are taken 
from table 5.12 and the estimated values derived from table 5.13. The general trends of the 
mean number of patients’ arrivals to the clinical centres are similar except for the last data, 
where the recruitment has a clear reduction. The average number of patients per centre per 
month is slightly underestimated in the last simulation. 
   
Simulated mean number of patients per centre per month based on four-month information from the example completed trial
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Figure 5.6: Line graph of the mean number of patients arrived to the centres per month in the real trial, 
marginal estimation, posterior estimation and the simulated trial 
 
 
5.7.2.  Prediction in time domain 
In this section we consider the more relevant question of how long it will take to complete the 
on-going trial. That is, at month 1 how long will it take to recruit the additional 136 patients, 
at month 2 how long will it take to recruit the additional 100 patients and at month 3 how long 
will it take to recruit 56 patients. 
In  this  research,  the  recruitment  frequency  data  were  used  for  almost  all  the  analysis. 
Therefore, the process of the simulation in the recruitment time required a movement from the 
frequency domain to the time domain. Due to the frequency domain of the recruitment data 
following the Poisson-gamma mixture, the time domain was assumed to have the Gamma-
exponential  mixture  distribution.  What  the  assumption  implies  is  that  the  waiting  times 
between patients follow the exponential distribution with parameter lambda, which itself is 
the Gamma distributed with parameters   , .  
 
1st month 2nd month 3rd month end of trial
Observed trial 4 3.25 3.2 3.25
Marginal estimation 4.02 2.93 2.83 2.99
Posterior estimation 4.59 3.28 3.00 2.97
Simulated trial 4.27 3.36 3.19 2.9
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In order to simulate the patients’ accrual time, waiting times between patients’ arrival should 
be estimated first. Accrual time is the length of time that it would take to recruit a number of 
patients in clinical centres. But the waiting time between patients is the delay time between 
two patients’ arrival into centres in a clinical trial. Therefore, by summing up the waiting time 
between patients we would get the accrual time for that number of patients.  
 
To simulate the waiting time between patients, first, N=12 pairs of the parameters k  and   
from the Normal distribution were generated.  Then, for each pair, n=152 random numbers 
from  the  Gamma  distribution  with  the  shape  parameter 
k
1
   and  the  scale  parameter 
  k  were  simulated.  These  numbers,  which  made  a  matrix  of  N=12  rows  and  n=152 
columns, were in fact the values of the parameter lambda of the exponential distribution. So 
far, there were 152 lambda values generated for each pair of the parameters. Consequently, 
for each centre (row) the mean numbers of the lambda values were calculated to get only one 
representative parameter of lambda generated from the Gamma distribution for each centre. 
After this step the simulated matrix had N=12 rows (centres) and one column (average of 
lambda values generated from gamma distribution).  
The lambda values that were generated from the Gamma distribution were supposed to be the 
parameters  of  the  Exponential  distribution.  Hence,  for  each  centre,  n=152  waiting  times 
between patients’ arrival were simulated from the Exponential distribution using the lambda 
values as the distribution parameters. The result was again a matrix of N=12 rows and n=152 
columns but in the new matrix the values represented waiting times between patients’ arrivals.  
 
Although the waiting times between patients’ arrivals to the centres had been simulated, there 
was no clue about the patients’ accrual time yet. To gain the answer, in the next step of the Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  90 
simulation  process,  the  waiting  times  in  centres  were  summed  up  to  calculate  the  total 
recruiting  time.  This,  however,  was  under  the  condition  that  all  the  centres  initiated 
simultaneously. But, in the completed trial, different centres were activated in different dates. 
This meant that some centres started to recruit patients with some sorts of delay from the start 
of the trial. There was no doubt that the delay had to be considered in the simulation as well. 
To address the issue, the delay of the first site was set to zero.  But the difference between the 
activation date of each centre and the first one was added to the matrix of the accrual time. 
The delay values were taken from the selected completed trial. Then, regardless of the centres, 
the whole data were sorted by their accrual time. As a result, a set of time data were generated, 
in which the ith value represented the length of time (in month) to recruit the ith patient in an 
on-going trial.  
 
The process explained above was repeated for the four data sets gathered in the four time 
intervals  of  monitoring  the  completed  trial.  In  fact,  the  four  data  sets  of  the  trial  were 
simulated separately to predict the accrual time based on the different recruiting data. Also, all 
the four sets of the simulation were run for 1000 times to be able to draw histograms of the 
accrual times. 
In the selected trial, 16 patients were recruited during the first month of initiating the trial. But 
after the second month of the start of the trial the arrivals increased to three times as many as 
the first month. 36 more patients had arrived into the clinical centres to increase the total 
number of patients to 52 by the end of the second month. After the third month, the total 
quantity of the patients was 96, which meant that the trial had accrued 44 patients during the 
third month. By the end of the trial 152 patients had arrived into the clinical centres (table 
5.12).  
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The line graph in figure 5.7 shows the sharp increasing trend of the recruitment process in the 
completed trial.  Also, the pie chart in figure 5.8 reveals by how much the number of patients 
went up after each month.  
 
 
 Figure 5.7: Line graph of the recruiting trend througout the trial 
 
Figure 5.8: Pie chart of the share of each time interval in recruiting patients 
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An important consideration here is that the increasing rate of the patient recruitment would 
affect the accrual time. Therefore, it is expected to view a decreasing trend in the accrual time 
as the trial goes on. This research aimed to predict the accrual time for the remaining patients 
based on the information in an on-going trial, which was gained in the different follow up 
times.  
 
Although  the  main  interest  was  to  predict  the  time  to  recruit  the  remaining  patients  to 
complete the on-going trial, which are illustrated in figures 5.12, 5.14 and 5.15, short term 
predictions  were  also  considered  (figures  5.10,  5.11  and  5.13).    They  were,  in  fact, 
comparisons between the simulated trial and the actual data. The histograms in figures 5.9, 
5.10, 5.11 and 5.13 are mainly to check the compatibility of the simulated on-going trial and 
the actual trial. While the results in figures 5.12, 5.14 and 5.15 are the answers to the main 
question of the research. They illustrate the expected time to recruit the remaining individuals 
from the total sample size of 152 patients if 16, 52 and 96 patients had already arrived to the 
centres in the past 1
st, 2
nd and 3
rd month of the trial, respectively.  
 
The first trial was simulated based on the first month follow up, during which 16 patients only 
were recruited. Figure 5.9 is the simulated accrual time to recruit 16 patients. It is basically to 
check the comparability of the real trial and the simulated one. The length of time to recruit 
16 patients estimated from 1000 simulation was stretched from 0.26 to 1.38 month (95% CI: 
0.48-1.2). It represented the example trial very well since the one month accrual time in the 
trial was included in the predicted 95% confidence interval.  Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  93 
Figure 5.9: Histogram of the simulated accrual time for 16 patients based on one month follow up 
 
The simulated trial, however, was mainly to predict the accrual time to recruit the remaining 
patients from the sample size. It had taken 1 month to recruit 36 more patients (52-16=36) in 
the completed trial after the 16 patients had already arrived into the clinical centres in the first 
month. The simulation predicted that it would be between 0.58 to 1.66 months (95% CI: 0.75-
1.43, median=1.09 months) (figure 5.10).  
Length of time to recruit 16 patients (based on one month information)
month
F
r
e
q
u
e
n
c
y
0 1 2 3 4
0
5
0
1
0
0
1
5
0
2
0
0Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  94 
 
Figure 5.10: Histogram of the predicted accrual time of 36 patients based on the assumption that 16 
patients had already arrived into the centres in the past month 
 
 
 
Based on 1000 simulation, it was predicted to take between 1.51 to 2.92 months (95% CI: 
1.73-2.47; median=2.10 months) for 80 more patients (96-16=80) to arrive the clinical centres 
if 16 patients had already done so in one month (figure 5.11). The value in the completed trial 
was 2 months, which is very similar to the predicted median and fell into the 95% confidence 
interval.  
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Figure 5.11: Histogram of the predicted accrual time of 80 patients based on the assumption that 16 
patients had already arrived into the centres in the past month 
 
 
If it was known that during the first month of the trial 16 patients had arrived into the centres, 
figure 5.12 shows the predicted accrual time for the remaining 136 patients out of the 152 
sample size (152-16=136). The simulated trial, predicted an average of 3.11 months. In 95% 
of the trials the accrual time for the remaining 136 patients was between 2.67 and 3.60 months.  
In the real trial the total accrual time was about 3.90 months. Considering the arrivals of 16 
patients in the first month, the accrual time for the remaining 136 patients had been about 2.90 
months and it was contained in the confidence interval. 
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Figure 5.12: Histogram of the predicted accrual time of 136 patients based on the assumption that 16 
patients had already arrived into the centres in the past month 
 
The second trial was simulated based on two months follow up of the completed trial, during 
which 52 patients had arrived into clinical centres. The simulation was first to predict how 
long it would take to recruit another 44 patients (96-52=44). According to the simulation 
result, it was predicted to take 0.86 month in average, which is less than one month. However, 
the one month accrual time for the extra 44 patients in the real trial was included in the 95% 
confidence interval of the prediction (CI: 0.63-1.08 months) (figure 5.13).  
 
Length of time to recruit 136 more patients if 16 patients had been already recruited (based on one month information)
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Figure 5.13: Histogram of the predicted accrual time of 44 patients based on the assumption that 52 
patients had already arrived into the centres in the past two months 
 
If it was to recruit 152 patients in a clinical trial, the question raised here could be how long it 
would take to recruit 100 individuals (152-52=100) if 52 had been recruited in the past two 
months. The 1000 simulations highlighted that the 95% confidence interval was expected to 
be between 1.40 and 1.96 months. The real accrual time for the remaining patients to arrive 
into centres was about 1.90 months which was very well covered by the predicted CI (figure 
5.14).  
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Figure 5.14: Histogram of the predicted accrual time of 100 patients based on the assumption that 52 
patients had already arrived into the centres in the past two months 
 
Finally, the simulated trial predicted the expected accrual time of 0.50 to 1.20(95% CI: 0.55 – 
0.88) months to recruit the 56 remaining individuals from the sample size of 152 patients(152-
96=56) in an on-going trial, in which 96 patients had been already recruited in three months. 
In the completed trial, the recruitment time for the remaining 56 patients was about 0.90 
months which has been slightly underestimated in the last simulation (figure 5.15). 
Length of time to recruit 100 more patients if 52 patients have already arrived into centres  (based on two months information)
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Figure 5.15: Histogram of the predicted accrual time of 56 patients based on the assumption that 96 
patients had already arrived into the centres in the past three months 
For the final view, table 5.14 shows how the predictions of the accrual time of the remaining 
patients changed based on the simulated on-going trials.  
Time 
intervals 
Patients to be 
recruited after 
each time 
interval 
Mean of the 
predicted time 
(month) to 
recruit the 
remaining 
individuals 
95% CI 
prediction for 
the time (month) 
to recruit the 
remaining 
patients 
Actual time to 
predict the 
remaining 
patients 
1st month  136  3.11  (2.67 - 3.60)  2.9 
2nd month  100  1.6  (1.40 - 1.96)  1.9 
3rd month  56  0.72  (0.56 - 0.88)  0.9 
Table 5.14: Summary table of the predicted accrual times based on the 1
st, 2
nd and 3
rd month data 
 
 
Overall, the aim of the project was achieved in the way that it was successful in using the 
frequency  domain  to  predict  the  time  domain  in  an  on-going  multi-centre  clinical  trial. 
Moreover, almost all of the predictions covered the accrual time of the real trial. 
   
Length of time to recruit 56 more patients if 96 patients have already arrived into the trial(based on three months information)
month
F
r
e
q
u
e
n
c
y
0 1 2 3 4
0
5
0
1
0
0
1
5
0
2
0
0Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  100 
 
Conclusion and discussion 
 
 
In this research an on-going trial was simulated using the data from completed trials provided 
by ICON. The overall approach was to model the frequency domain from recruitment data 
and move smoothly to predict the time domain.  
 
The frequency of patients’ arrivals  was  modelled as  if they  followed the Poisson-gamma 
mixture distribution with the accrual times included in the model as the offset variables. Then, 
the waiting times between patients were simulated based on the assumption that they were 
Gamma-exponential  distributed.  The  total  recruitment  time  for  a  pre-fixed  number  of 
individuals were predicted by summing up the waiting times between the patients’ arrivals.  
 
The main interest was to predict the accrual time of the remaining individuals in an on-going 
trial. As an example, in the trial in which 152 patients were to be recruited by the end of the 
trial, the main interest was to predict the time to recruit the remaining 136 patients if 16 
patients  had  already  been  taken  into  the  clinical  centres  in  the  first  month  of  the  trial. 
However, short term predictions were applied as well to see whether the simulated trials 
provided similar time to the actual trials. To make it clearer, in the example above, the time to 
recruit 36 more patients was also predicted if 16 patients had already arrived by the end of the 
first month. Hence, the short term prediction was basically to see if the predicted recruiting 
time for 36 more patients is close to the actual recruiting time in the selected trial. Overall, 
three  different  on-going  trials  were  simulated  based  on  the  information  of  the  follow  up Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  101 
intervals of a selected completed trial. Initially, the simulations predicted the expected number 
of recruitments per centre per month derived from the 1
st, 2
nd and 3
rd month recruitment 
information. Then the expected length of time (month) to recruit the remaining number of 
patients and complete the trial was predicted based on the one, two and three months of data 
collection. 
 
As regards the frequency domain, the comparison results between the simulated trials and the 
actual data were very reasonable. The average frequencies of the completed trials were well 
covered by the 95% confidence intervals of the expected values predicted from the simulated 
on-going trials. The exception, however, was the first simulation which slightly overestimated 
the average number of patients per centre per month.  The average number of patients per 
centre  per  month  is  expected  to  remain  unchanged  throughout  the  trial.  This  value  is 
remarkably more in the first month of the actual trial. That could be the reason of the over-
estimation outcome. The line graph in figure 5.6 compares the expected number of individuals 
to be recruited in the simulated on-going trials and the actual completed trial in different time 
steps.  
 
In  the  main  forecasting  area,  the  time  domain,  the  predictions  of  the  time  to  accrue  the 
remaining individuals from the pre-arranged sample size were reasonable compared to the 
values in the actual trial. Although it may imply that the real accrual time of the remaining 
patients in the 3
rd trial has been underestimated by the 3
rd simulation, it is located in the upper 
end of the histogram.  
 
In  the  first  simulated  trial,  the  question  was  that  how  long  it  would  take  to  recruit  the 
remaining 136 patients (152 patients to be recruited) if 16 patients had already arrived into the Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  102 
clinical centres during the first month of the trial. The recruitment time in the actual trial was 
about 3.90 month for the sample size of the 152 individuals and 16 patients were recruited by 
the end of the first month of the trial. Hence, the accrual time for the remaining 136 patients 
was  2.90  months.  The  relative  simulated  on-going  trial,  with  95%  confidence  interval, 
predicted that the recruitment time for the remaining 136 patients is between 2.67 and 3.60 
month, which was a reasonable result.  
In the second data set that was derived from the actual trial, 52 patients had arrived into the 
centres by the end of the second month. So, the time for the remaining 100 patients to enter 
the  trial  was  1.90  months.  The  second  simulation  (based  on  the  two-month  information) 
suggested 1.40-1.96 months in its 95% confidence interval. It is an acceptable result, although 
the value of the actual trial is moving towards the upper end of the CI.  
By the end of the 3
rd month, the trial had recruited 96 patients and took less than a month to 
take the remaining 56 individuals. However, in a 95% confidence interval, the simulated trial 
predicted a range of 0.56 to 0.88 months for 56 patients to be accrued in the clinical trial. As a 
discussion,  it  implies  that  it  may  slightly  underestimate  the  accrual  time  if  the  model  is 
applied. This is due to the observed data being at the upper end of the confidence interval.   
 
Overall, the main purpose of the research was to predict the patients accrual time in an on-
going clinical trial. It was in fact to forecast the recruitment time for the remaining patients in 
an on-going trial. Since the recruitment data were better presented in the frequency domain, 
the  project  had  to  manage  to  use  the  recruitment  data  from  the  completed  trials  in  the 
frequency domain to forecast the recruitment in the time domain in an on-going trial. In future, 
we could improve the recruitment prediction by applying the statistical distribution to the time 
domain directly. In this case the Pearson VI distribution that was suggested by Anisimov et al 
would be a more reasonable fit.    Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  103 
 
 
Appendix 1 
 
 
Parameters of Negative Binomial distribution were estimated applying maximum likelihood 
estimation method in R.  
 
### *** Analysing  recruitment data by fitting Negative Binomial distribution to the 
frequency domain with parameters r=alpha   ,    p=1/(1+beta)*** ### 
# log-likelihood function # 
log.like    <-function(par,x)   
{ 
a  <- log(gamma(x+par[1])) 
b  <- length(x)* log(gamma(par[1])) 
c  <- length(x)*par[1]*log(par[2]+1) 
d  <- x*log(par[2]/(par[2]+1)) 
e  <- log(gamma(x+1)) 
log.like    <-sum(a)-b-c+sum(d)-sum(e) 
} 
# To optimize the function starting from lowest number of patient in centres for alpha(here is 
2),  beta=mean/alpha (here is 8)# 
estimation  <-optim(c(2,8),log.like, control=list(fnscale=-1) , hessian=TRUE, x=patients) 
estimation 
 
alpha  <-estimation$par[1]    #estimated parameter alpha# 
beta  <-estimation$par[2]    #estimated parameter beta# 
p  <-1/(1+beta)      #scale parameter in NB distribution# 
m.u  <- alpha*(1-p)/p     #mean number of values in NB # 
variance  <-alpha*(1-p)/(p^2)    #variance of data in NB distribution# 
s.d  <-  variance^.5     #standard deviation# Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  104 
#standard error of the parameter# 
se.par  <- sqrt(diag(-solve(estimation$hessian))) 
   
### **** confidence intervals for alpha and beta *** ### 
b    <- c(1,0)  # vector to consider alpha only(the first parameter)# 
lower.alpha  <-(t(b)%*%estimation$par)-(1.96*sqrt(t(b)%*%(-
solve(estimation$hessian))%*%b)) 
upper.alpha  <-(t(b)%*%estimation$par)+(1.96*sqrt(t(b)%*%(-
solve(estimation$hessian))%*%b)) 
# the vector to consider beta only  (the second parameter)# 
b    <- c(0,1)   
k    <-(-estimation$hessian)  # the sample information matrix# 
lower.beta<-(t(b)%*%estimation$par)-(1.96*sqrt(t(b)%*%(-
solve(estimation$hessian))%*%b))        #lower band for the CI# 
upper.beta<-(t(b)%*%estimation$par)+(1.96*sqrt(t(b)%*%(-
solve(estimation$hessian))%*%b))        #upper band for the CI# 
 
# Estimating parameters using Maximum Likelihood Method in MASS package # 
library(MASS)            # laoding package MASS # 
fitdistr(patients , "negative binomial")   # fitting Negative binomial parameters #  
 
### *** log-likelihood contour plot *** ### 
ngrid  <-60               # Produce the number of grid lines# 
alpha  <-seq(1,5,length=ngrid)       # location of grid line of parameter alpha # 
P  <- seq( 0, 1, length=ngrid)       #location of grid line of  parameter p # 
# Make a data frame and then matrix from alpha and p# 
grid  <-as.matrix(expand.grid(alpha,p))   
log.like    <-rep(0, nrow(grid)) 
n    <-24      #Number of patients in the centre#     
for (i in 1:n)        # to calculate the log-likelihood for the given data# 
{ 
  log.like      <-log.like+log(dnbinom(patients[i], grid[,1], grid[,2])) 
  log.like[log.like  <-150] <-NA Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  105 
  log.like      <-matrix(log.like, nrow=ngrid) 
} 
 
contour (alpha, p, log.like)   
#Draw the contour plot with x=alpha, y=p, z=log-likelihood# 
title(xlab="alpha", ylab="p", main="Likelihood function") 
text(1.273, .073, "max") 
 
image (alpha, p, log.like)      #Image of the contour plot# 
text(1.273, .073, "max")      #Label the MLE value# 
 
### *** panel *** ### 
library(rpanel) 
log.like    <-function(theta, data)     
# writing the likelihood function separately then adding all togetherfor simplicity# 
{  par  <-theta 
  x  <-data 
  a  <- log(gamma(x+par[1])) 
  b  <- length(x)* log(gamma(par[1])) 
  c  <- length(x)*par[1]*log(par[2]+1) 
  d  <- x*log(par[2]/(par[2]+1)) 
  e  <- log(gamma(x+1)) 
log.like<-sum(a)-b-c+sum(d)-sum(e) 
invisible (sum(a)-b-c+sum(d)-sum(e)) 
} 
# Draw the panel for log-likelihood estimated parameters# 
rp.likelihood(log.like, patients, c(0.1, 2), c(2, 8) )      
rp.likelihood("sum(dnbinom(data, theta[2], theta[1], log = TRUE))",   patients, c(0.1, 2), c(0.9, 
4)) 
 
### *** Goodness of fit test *** ### 
### *** H0: the data follow NB distribution  *** ## 
library (vcd) Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  106 
gf.NB  <-  goodfit(patients,type= "nbinomial", method= "MinChisq") 
summary(gf.NB) 
 
### *** estimating parameters applying method of moments *** ### 
x.bar    <- mean (patients)    # expected value from the sample # 
s2.bar    <-  var(patients)    # variance from the sample# 
alpha.moment <- x.bar^2/s2.bar    # estimating alpha from the mean and variance # 
beta.moment  <- x.bar/alpha.moment  # estimating beta from alpha and mean# 
p.moment  <- 1/(1+beta.moment) # estimating probabity from its relationship with beta#
   
 
# *** qplot *** # 
#to check if the number of patients recruited follow the negative binomial distribution# 
plot(qnbinom(ppoints(patients), size=1.274, mu=16.044), sort(patients), xlab=" 
Empericalquantiles from NB", ylab="sample empericalquantile") 
abline(0,1) #drawing a 45-degree reference line# 
 
### *** emperical density functions *** ### 
#producing random numbers from NB distribution with the given parameters# 
y<-rnbinom(24,size=1.274,prob=.074) 
#to draw the cumulative functions in one window# 
Par(mfrow=c(1,2)) 
# to plot empirical cumulative distribution function for recruited patients # 
plot.ecdf(patients, verticals = TRUE, pch=19, col="red",  
xlab="Number of patients per country", ylab="probability function", main= "Empirical 
cumulative step function, study 1") 
 
#empirical cumulative step function plot for the random NB values# 
plot.ecdf(y, verticals=TRUE, pch=19, col="darkblue",  
xlab="Negative Binomial random Values", ylab="probability function") 
 
### *** Histogram with fitted distribution *** ### 
#histogram of the patients recruited# Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  107 
hist(patients, freq=FALSE, xlim=c(0,80),  
col="lightblue", border="red", plot=TRUE,  
xlab="Number of patients recruited", ylab="Probability densities",  
main="Histogram of recruited patients with the fitted NB in study1")     
   
 
x<-seq(2,80,1)           #produce a sequence of numbers from 2 
to 80# 
fn.nb<-dnbinom(x,size=1.274,prob=.074)    #calculate a function of negative 
binomial distribution with the given parameters# 
lines(x,fn.nb)            # Negative binomial curve for the given 
parameters # 
 
### *** kernel density plot *** ### 
d <- density(patients)         # to estimate the frequency density of the 
data#     
plot(d, main="Kernel Density of patients in study 1") 
polygon(d, col="red", border="red")  
 
### *** Analysing the number of patients by fitting Negative Binomial distribution with 
parameters r=alpha*N and p=t/beta *** ### 
### *** N  isthe number of clinical centres and t is the total recruitment time  *** ### 
#The log-likelihood function for NB distribution with parameters alpha*N and t/beta ## 
logl<-function(par,y,N,t)   
{ 
a<-log(gamma(y+par[1]*N)) 
b<-length(y)*log(gamma(par[1]*N)) 
c<-log(gamma(y+1)) 
d<-y*log((t/(t+par[2]))) 
e<-length(y)*par[1]*N*log(par[2]/(t+par[2])) 
logl<-sum(a)-b-sum(c)+sum(d)+e 
} 
logl Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  108 
 
est<-optim(c(2,5),logl, control=list(fnscale=-1),hessian=TRUE, y=patients, 
N=length(country),t=max(time.month))# to estimate the parameter alpha=par[1] and 
beta=par[2] by maximising the function # 
est 
 
alphat<- est$par[1] 
betat<- est$par[2] 
shape<- alphat * N 
scale<- max(time.month)/betat Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  109 
 
 
Appendix 2 
 
Notes regarding the influence of units of time in 
modelling the Poisson process on the time or 
frequency domain. 
 
Suppose we have a Poisson process with mean  observed for time 1 T  . Note, in practice, 
T is not unit-free it will have to have units attached. To take a concrete example, we might 
have 1 T year  . The probability mass function for the number of events  X  is given by the 
Poisson distribution with 
   
!
xe
P X x
x
 

 .(1.1) 
 
Note also that the   that is used must be the   that is consistent withT . This   is a rate 
parameter and if the rate parameter is defined with respect to a different period of observation 
it  must  be  adjusted  accordingly  so  that  when  substituted  in (1.1)  it  gives  the  correct 
probability. For example if we choose to define  as a rate per month but observe the process 
for a year we must substitute 12  for  in (1.1). Note that the mean of the resulting Poisson 
is 12  and its variance is also12 . This is because the resulting probability distribution does 
not involve any multiplication of  X . Mere multiplication of an  X that was observed for one 
month  by  12  would  no  longer  result  in  a  Poisson  distribution.  Instead  we  would  have  a 
random variable with mean 12 times as large and variance 
2 12 144  times as large. On the 
other hand observing a Poisson process for 12 months and adding together the 12 independent 
random variables consisting of the numbers in each month would give a total that was still 
Poisson with expectation and variance of 12 . 
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Let the inter-arrival time be Z . The mean inter-arrival time is  1   . Note that   is also 
not unit free  and must  be measured in the same time units asZ . The probability density 
function for inter-arrival times is an exponential distribution with 
   
1
.
z
z f Z z e dz e dz
  


    (1.2) 
Now suppose that we choose to measure in new time units t. If we create a new random 
variableY tZ  then  ,, y tz z y t dz dy t     and so we have 
    .
y
t f Y y e dy
t
  
 (1.3) 
To take a concrete example, we might decide to measure in days rather than years. In that case 
we would have  365 t days year  . Clearly this new random variable is also an exponential 
distribution with mean 
* tt     .  
 
The gamma distribution which includes (1.2) as a special case is given by 
     
1 1
w
g W w e w dw
 
 

 

.  (1.4) 
Clearly by setting  1   in (1.4) and  , W Z z w  we get (1.2). Specifically, if  takes on a 
positive integer value and we define 
 
1
i
i
WZ


   (1.5) 
as the sum of  inter-arrival times then (1.4) can be used as the waiting time until   events 
occur. More generally, however, we can let   be some positive real number and apply a 
distribution like (1.4) as a mixing distribution for a Poisson process itself. 
 
If, analogously to the case with the exponential distribution, we create a new random variable 
V tW  then  ,, v tw w v t dw dv t    and then substitute in (1.4) we get  
        
1
1 1 1 1
vv
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tt t
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  (1.6) 
Clearly this is a gamma distribution with parameters  ,t   rather than  , . Note also that 
(1.4) has mean   and variance 
2  . Whereas (1.6) has mean  t  and variance 
22 t . Andisheh Bakhshi    Supervisor: Prof. Stephen Senn  111 
This is clearly appropriate since the random variable V  is simply created by multiplying the 
random variable W by a constant  . t  
 
Stephen Senn, 7 June 2011 
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